BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1126662 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H27ClFN5O3/c1-37-25-10-9-22(30)27(32-25)28(36)35-20-11-13-33(14-21(35)17-38-16-20)15-23-26(18-5-7-19(29)8-6-18)31-24-4-2-3-12-34(23)24/h2-10,12,20-21H,11,13-17H2,1H3 LCTJPPMPLZJFSE-UHFFFAOYSA-N 532051 3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-3-yl]methyl}-8-oxa-3,10-diazabicyclo[4.3.1]dec-10-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1)::US11208422, Example 11::US11208422, Example 12::US11208422, Example 92 Potassium channel subfamily K member 3 Human 11.4 US Patent 10.7270/Q2CR5XHD aid1806236 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532051&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602402 463795483 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126664 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H27ClFN5O3/c1-37-25-10-9-22(30)27(32-25)28(36)35-20-11-13-33(14-21(35)17-38-16-20)15-23-26(18-5-7-19(29)8-6-18)31-24-4-2-3-12-34(23)24/h2-10,12,20-21H,11,13-17H2,1H3 LCTJPPMPLZJFSE-UHFFFAOYSA-N 532051 3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-3-yl]methyl}-8-oxa-3,10-diazabicyclo[4.3.1]dec-10-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1)::US11208422, Example 11::US11208422, Example 12::US11208422, Example 92 Potassium channel subfamily K member 3 Human 17.6 US Patent 10.7270/Q2CR5XHD aid1806236 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532051&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602402 463795483 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126666 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H26ClFN6O3/c1-37-23-8-7-21(29)25(31-23)26(36)35-19-9-12-33(13-20(35)16-38-15-19)14-22-24(17-3-5-18(28)6-4-17)32-27-30-10-2-11-34(22)27/h2-8,10-11,19-20H,9,12-16H2,1H3 TUPUGKCVCFZDOC-UHFFFAOYSA-N 532162 3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-8-oxa-3,10-diazabicyclo[4.3.1]dec-10-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1)::US11208422, Example 13::US11208422, Example 14::US11208422, Example 93 Potassium channel subfamily K member 3 Human 40.3 US Patent 10.7270/Q2CR5XHD aid1806236 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532162&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602416 463795593 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126668 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H26ClFN6O3/c1-37-23-8-7-21(29)25(31-23)26(36)35-19-9-12-33(13-20(35)16-38-15-19)14-22-24(17-3-5-18(28)6-4-17)32-27-30-10-2-11-34(22)27/h2-8,10-11,19-20H,9,12-16H2,1H3 TUPUGKCVCFZDOC-UHFFFAOYSA-N 532162 3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-8-oxa-3,10-diazabicyclo[4.3.1]dec-10-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1)::US11208422, Example 13::US11208422, Example 14::US11208422, Example 93 Potassium channel subfamily K member 3 Human 20.6 US Patent 10.7270/Q2CR5XHD aid1806236 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532162&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602416 463795593 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126670 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cn1)CC2 InChI=1S/C27H26ClFN6O2/c1-37-24-10-8-20(29)25(32-24)27(36)35-18-6-7-19(35)15-33(13-11-18)16-22-26(21-9-5-17(28)14-30-21)31-23-4-2-3-12-34(22)23/h2-5,8-10,12,14,18-19H,6-7,11,13,15-16H2,1H3 AZANSRINWIMRPB-UHFFFAOYSA-N 532166 US11208422, Example 15::US11208422, Example 16::[3-{[2-(5-Chloropyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl}-3,9-diazabicyclo[4.2.1]non-9-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1) Potassium channel subfamily K member 3 Human 7.54 US Patent 10.7270/Q2CR5XHD aid1806236 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532166&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146524917 463795596 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126672 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H26ClFN6O3/c1-37-23-8-7-21(29)25(31-23)26(36)35-19-9-12-33(13-20(35)16-38-15-19)14-22-24(17-3-5-18(28)6-4-17)32-27-30-10-2-11-34(22)27/h2-8,10-11,19-20H,9,12-16H2,1H3 TUPUGKCVCFZDOC-UHFFFAOYSA-N 532162 3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-8-oxa-3,10-diazabicyclo[4.3.1]dec-10-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1)::US11208422, Example 13::US11208422, Example 14::US11208422, Example 93 Potassium channel subfamily K member 3 Human 35.1 US Patent 10.7270/Q2CR5XHD aid1806236 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532162&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602416 463795593 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126674 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H27ClFN5O3/c1-37-25-10-9-22(30)27(32-25)28(36)35-20-11-13-33(14-21(35)17-38-16-20)15-23-26(18-5-7-19(29)8-6-18)31-24-4-2-3-12-34(23)24/h2-10,12,20-21H,11,13-17H2,1H3 LCTJPPMPLZJFSE-UHFFFAOYSA-N 532051 3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-3-yl]methyl}-8-oxa-3,10-diazabicyclo[4.3.1]dec-10-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1)::US11208422, Example 11::US11208422, Example 12::US11208422, Example 92 Potassium channel subfamily K member 3 Human 113 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532051&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602402 463795483 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126675 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H27ClFN5O3/c1-37-25-10-9-22(30)27(32-25)28(36)35-20-11-13-33(14-21(35)17-38-16-20)15-23-26(18-5-7-19(29)8-6-18)31-24-4-2-3-12-34(23)24/h2-10,12,20-21H,11,13-17H2,1H3 LCTJPPMPLZJFSE-UHFFFAOYSA-N 532051 3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-3-yl]methyl}-8-oxa-3,10-diazabicyclo[4.3.1]dec-10-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1)::US11208422, Example 11::US11208422, Example 12::US11208422, Example 92 Potassium channel subfamily K member 9 Homo sapiens 1.10 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532051&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602402 463795483 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126676 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H27ClFN5O3/c1-37-25-10-9-22(30)27(32-25)28(36)35-20-11-13-33(14-21(35)17-38-16-20)15-23-26(18-5-7-19(29)8-6-18)31-24-4-2-3-12-34(23)24/h2-10,12,20-21H,11,13-17H2,1H3 LCTJPPMPLZJFSE-UHFFFAOYSA-N 532051 3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-3-yl]methyl}-8-oxa-3,10-diazabicyclo[4.3.1]dec-10-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1)::US11208422, Example 11::US11208422, Example 12::US11208422, Example 92 Potassium channel subfamily K member 3 Human 60.5 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532051&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602402 463795483 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126677 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H27ClFN5O3/c1-37-25-10-9-22(30)27(32-25)28(36)35-20-11-13-33(14-21(35)17-38-16-20)15-23-26(18-5-7-19(29)8-6-18)31-24-4-2-3-12-34(23)24/h2-10,12,20-21H,11,13-17H2,1H3 LCTJPPMPLZJFSE-UHFFFAOYSA-N 532051 3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-3-yl]methyl}-8-oxa-3,10-diazabicyclo[4.3.1]dec-10-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1)::US11208422, Example 11::US11208422, Example 12::US11208422, Example 92 Potassium channel subfamily K member 9 Homo sapiens 2.50 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532051&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602402 463795483 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126678 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H26ClFN6O3/c1-37-23-8-7-21(29)25(31-23)26(36)35-19-9-12-33(13-20(35)16-38-15-19)14-22-24(17-3-5-18(28)6-4-17)32-27-30-10-2-11-34(22)27/h2-8,10-11,19-20H,9,12-16H2,1H3 TUPUGKCVCFZDOC-UHFFFAOYSA-N 532162 3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-8-oxa-3,10-diazabicyclo[4.3.1]dec-10-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1)::US11208422, Example 13::US11208422, Example 14::US11208422, Example 93 Potassium channel subfamily K member 3 Human 1000 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532162&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602416 463795593 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126679 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H26ClFN6O3/c1-37-23-8-7-21(29)25(31-23)26(36)35-19-9-12-33(13-20(35)16-38-15-19)14-22-24(17-3-5-18(28)6-4-17)32-27-30-10-2-11-34(22)27/h2-8,10-11,19-20H,9,12-16H2,1H3 TUPUGKCVCFZDOC-UHFFFAOYSA-N 532162 3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-8-oxa-3,10-diazabicyclo[4.3.1]dec-10-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1)::US11208422, Example 13::US11208422, Example 14::US11208422, Example 93 Potassium channel subfamily K member 9 Homo sapiens 2.20 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532162&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602416 463795593 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126680 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H26ClFN6O3/c1-37-23-8-7-21(29)25(31-23)26(36)35-19-9-12-33(13-20(35)16-38-15-19)14-22-24(17-3-5-18(28)6-4-17)32-27-30-10-2-11-34(22)27/h2-8,10-11,19-20H,9,12-16H2,1H3 TUPUGKCVCFZDOC-UHFFFAOYSA-N 532162 3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-8-oxa-3,10-diazabicyclo[4.3.1]dec-10-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1)::US11208422, Example 13::US11208422, Example 14::US11208422, Example 93 Potassium channel subfamily K member 3 Human 760 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532162&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602416 463795593 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126681 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H26ClFN6O3/c1-37-23-8-7-21(29)25(31-23)26(36)35-19-9-12-33(13-20(35)16-38-15-19)14-22-24(17-3-5-18(28)6-4-17)32-27-30-10-2-11-34(22)27/h2-8,10-11,19-20H,9,12-16H2,1H3 TUPUGKCVCFZDOC-UHFFFAOYSA-N 532162 3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-8-oxa-3,10-diazabicyclo[4.3.1]dec-10-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1)::US11208422, Example 13::US11208422, Example 14::US11208422, Example 93 Potassium channel subfamily K member 9 Homo sapiens 4.50 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532162&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602416 463795593 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126682 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cn1)CC2 InChI=1S/C27H26ClFN6O2/c1-37-24-10-8-20(29)25(32-24)27(36)35-18-6-7-19(35)15-33(13-11-18)16-22-26(21-9-5-17(28)14-30-21)31-23-4-2-3-12-34(22)23/h2-5,8-10,12,14,18-19H,6-7,11,13,15-16H2,1H3 AZANSRINWIMRPB-UHFFFAOYSA-N 532166 US11208422, Example 15::US11208422, Example 16::[3-{[2-(5-Chloropyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl}-3,9-diazabicyclo[4.2.1]non-9-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1) Potassium channel subfamily K member 3 Human 250 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532166&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146524917 463795596 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126683 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cn1)CC2 InChI=1S/C27H26ClFN6O2/c1-37-24-10-8-20(29)25(32-24)27(36)35-18-6-7-19(35)15-33(13-11-18)16-22-26(21-9-5-17(28)14-30-21)31-23-4-2-3-12-34(22)23/h2-5,8-10,12,14,18-19H,6-7,11,13,15-16H2,1H3 AZANSRINWIMRPB-UHFFFAOYSA-N 532166 US11208422, Example 15::US11208422, Example 16::[3-{[2-(5-Chloropyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl}-3,9-diazabicyclo[4.2.1]non-9-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1) Potassium channel subfamily K member 9 Homo sapiens 7.30 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532166&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146524917 463795596 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126684 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cn1)CC2 InChI=1S/C27H26ClFN6O2/c1-37-24-10-8-20(29)25(32-24)27(36)35-18-6-7-19(35)15-33(13-11-18)16-22-26(21-9-5-17(28)14-30-21)31-23-4-2-3-12-34(22)23/h2-5,8-10,12,14,18-19H,6-7,11,13,15-16H2,1H3 AZANSRINWIMRPB-UHFFFAOYSA-N 532166 US11208422, Example 15::US11208422, Example 16::[3-{[2-(5-Chloropyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl}-3,9-diazabicyclo[4.2.1]non-9-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1) Potassium channel subfamily K member 3 Human 1700 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532166&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146524917 463795596 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126685 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cn1)CC2 InChI=1S/C27H26ClFN6O2/c1-37-24-10-8-20(29)25(32-24)27(36)35-18-6-7-19(35)15-33(13-11-18)16-22-26(21-9-5-17(28)14-30-21)31-23-4-2-3-12-34(22)23/h2-5,8-10,12,14,18-19H,6-7,11,13,15-16H2,1H3 AZANSRINWIMRPB-UHFFFAOYSA-N 532166 US11208422, Example 15::US11208422, Example 16::[3-{[2-(5-Chloropyridin-2-yl)imidazo[1,2-a]pyridin-3-yl]methyl}-3,9-diazabicyclo[4.2.1]non-9-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1) Potassium channel subfamily K member 9 Homo sapiens 65.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532166&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146524917 463795596 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126686 COc1ccc(F)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H26ClFN6O2/c1-37-23-10-9-21(29)25(31-23)26(36)34-14-11-19-7-8-20(34)15-33(19)16-22-24(17-3-5-18(28)6-4-17)32-27-30-12-2-13-35(22)27/h2-6,9-10,12-13,19-20H,7-8,11,14-16H2,1H3 WXJHUHDRCAXWGL-UHFFFAOYSA-N 532169 US11208422, Example 17::US11208422, Example 33::[6-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,6-diazabicyclo[3.2.2]non-2-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 2) Potassium channel subfamily K member 3 Human 3300 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532169&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137363750 463795597 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126687 COc1ccc(F)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H26ClFN6O2/c1-37-23-10-9-21(29)25(31-23)26(36)34-14-11-19-7-8-20(34)15-33(19)16-22-24(17-3-5-18(28)6-4-17)32-27-30-12-2-13-35(22)27/h2-6,9-10,12-13,19-20H,7-8,11,14-16H2,1H3 WXJHUHDRCAXWGL-UHFFFAOYSA-N 532169 US11208422, Example 17::US11208422, Example 33::[6-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,6-diazabicyclo[3.2.2]non-2-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 2) Potassium channel subfamily K member 9 Homo sapiens 15.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532169&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137363750 463795597 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126688 COc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cn1 InChI=1S/C27H27ClN6O2/c1-36-25-7-4-5-22(30-25)27(35)33-14-12-19-9-10-20(33)16-32(19)17-23-26(21-11-8-18(28)15-29-21)31-24-6-2-3-13-34(23)24/h2-8,11,13,15,19-20H,9-10,12,14,16-17H2,1H3 DEXCHNPBIXIBCC-UHFFFAOYSA-N 532170 US11208422, Example 18 Potassium channel subfamily K member 3 Human 1600 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532170&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 142494548 463795598 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126689 COc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cn1 InChI=1S/C27H27ClN6O2/c1-36-25-7-4-5-22(30-25)27(35)33-14-12-19-9-10-20(33)16-32(19)17-23-26(21-11-8-18(28)15-29-21)31-24-6-2-3-13-34(23)24/h2-8,11,13,15,19-20H,9-10,12,14,16-17H2,1H3 DEXCHNPBIXIBCC-UHFFFAOYSA-N 532170 US11208422, Example 18 Potassium channel subfamily K member 9 Homo sapiens 167 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532170&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 142494548 463795598 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126690 COc1ccc(F)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cn1 InChI=1S/C27H26ClFN6O2/c1-37-24-10-8-20(29)25(32-24)27(36)34-13-11-18-6-7-19(34)15-33(18)16-22-26(21-9-5-17(28)14-30-21)31-23-4-2-3-12-35(22)23/h2-5,8-10,12,14,18-19H,6-7,11,13,15-16H2,1H3 CIEUSOSGSUZNSL-UHFFFAOYSA-N 532171 US11208422, Example 19 Potassium channel subfamily K member 3 Human 13500 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532171&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362157 463795599 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126691 COc1ccc(F)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cn1 InChI=1S/C27H26ClFN6O2/c1-37-24-10-8-20(29)25(32-24)27(36)34-13-11-18-6-7-19(34)15-33(18)16-22-26(21-9-5-17(28)14-30-21)31-23-4-2-3-12-35(22)23/h2-5,8-10,12,14,18-19H,6-7,11,13,15-16H2,1H3 CIEUSOSGSUZNSL-UHFFFAOYSA-N 532171 US11208422, Example 19 Potassium channel subfamily K member 9 Homo sapiens 580 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532171&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362157 463795599 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126692 COc1ccc(Cl)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cn1 InChI=1S/C27H26Cl2N6O2/c1-37-24-10-8-20(29)25(32-24)27(36)34-13-11-18-6-7-19(34)15-33(18)16-22-26(21-9-5-17(28)14-30-21)31-23-4-2-3-12-35(22)23/h2-5,8-10,12,14,18-19H,6-7,11,13,15-16H2,1H3 QLQILLKXFNHOQC-UHFFFAOYSA-N 532172 US11208422, Example 20 Potassium channel subfamily K member 3 Human 3350 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532172 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532172&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362169 463795600 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126693 COc1ccc(Cl)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cn1 InChI=1S/C27H26Cl2N6O2/c1-37-24-10-8-20(29)25(32-24)27(36)34-13-11-18-6-7-19(34)15-33(18)16-22-26(21-9-5-17(28)14-30-21)31-23-4-2-3-12-35(22)23/h2-5,8-10,12,14,18-19H,6-7,11,13,15-16H2,1H3 QLQILLKXFNHOQC-UHFFFAOYSA-N 532172 US11208422, Example 20 Potassium channel subfamily K member 9 Homo sapiens 197 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532172 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532172&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362169 463795600 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126694 COc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H27ClN6O2/c1-36-24-5-2-4-22(30-24)26(35)33-15-12-20-10-11-21(33)16-32(20)17-23-25(18-6-8-19(28)9-7-18)31-27-29-13-3-14-34(23)27/h2-9,13-14,20-21H,10-12,15-17H2,1H3 AOLFRRHHULQGIB-UHFFFAOYSA-N 532173 US11208422, Example 21::US11208422, Example 32 Potassium channel subfamily K member 3 Human 18000 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532173&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602562 463795601 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126695 COc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H27ClN6O2/c1-36-24-5-2-4-22(30-24)26(35)33-15-12-20-10-11-21(33)16-32(20)17-23-25(18-6-8-19(28)9-7-18)31-27-29-13-3-14-34(23)27/h2-9,13-14,20-21H,10-12,15-17H2,1H3 AOLFRRHHULQGIB-UHFFFAOYSA-N 532173 US11208422, Example 21::US11208422, Example 32 Potassium channel subfamily K member 9 Homo sapiens 140 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532173&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602562 463795601 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126696 Fc1ccccc1C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H25ClFN5O/c28-19-8-6-18(7-9-19)25-24(34-14-3-13-30-27(34)31-25)17-32-16-21-11-10-20(32)12-15-33(21)26(35)22-4-1-2-5-23(22)29/h1-9,13-14,20-21H,10-12,15-17H2 RDQHPRSHKJAASF-UHFFFAOYSA-N 532174 US11208422, Example 22::US11208422, Example 25 Potassium channel subfamily K member 3 Human 27000 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532174&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362137 463795602 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126697 Fc1ccccc1C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H25ClFN5O/c28-19-8-6-18(7-9-19)25-24(34-14-3-13-30-27(34)31-25)17-32-16-21-11-10-20(32)12-15-33(21)26(35)22-4-1-2-5-23(22)29/h1-9,13-14,20-21H,10-12,15-17H2 RDQHPRSHKJAASF-UHFFFAOYSA-N 532174 US11208422, Example 22::US11208422, Example 25 Potassium channel subfamily K member 9 Homo sapiens 370 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532174&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362137 463795602 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126698 COc1ccc(Cl)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H26Cl2N6O2/c1-37-23-10-9-21(29)25(31-23)26(36)34-14-11-19-7-8-20(34)15-33(19)16-22-24(17-3-5-18(28)6-4-17)32-27-30-12-2-13-35(22)27/h2-6,9-10,12-13,19-20H,7-8,11,14-16H2,1H3 ZCTGOWNNSZLJJU-UHFFFAOYSA-N 532175 US11208422, Example 23::US11208422, Example 34 Potassium channel subfamily K member 3 Human 3000 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532175&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362084 463795603 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126699 COc1ccc(Cl)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H26Cl2N6O2/c1-37-23-10-9-21(29)25(31-23)26(36)34-14-11-19-7-8-20(34)15-33(19)16-22-24(17-3-5-18(28)6-4-17)32-27-30-12-2-13-35(22)27/h2-6,9-10,12-13,19-20H,7-8,11,14-16H2,1H3 ZCTGOWNNSZLJJU-UHFFFAOYSA-N 532175 US11208422, Example 23::US11208422, Example 34 Potassium channel subfamily K member 9 Homo sapiens 24.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532175&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362084 463795603 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126700 Nc1nonc1C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C23H23ClN8O2/c24-15-4-2-14(3-5-15)19-18(32-10-1-9-26-23(32)27-19)13-30-12-17-7-6-16(30)8-11-31(17)22(33)20-21(25)29-34-28-20/h1-5,9-10,16-17H,6-8,11-13H2,(H2,25,29) UFHPCUKTTFMBQW-UHFFFAOYSA-N 532176 US11208422, Example 24::US11208422, Example 35 Potassium channel subfamily K member 3 Human 3100 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532176&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362126 463795604 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126701 Nc1nonc1C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C23H23ClN8O2/c24-15-4-2-14(3-5-15)19-18(32-10-1-9-26-23(32)27-19)13-30-12-17-7-6-16(30)8-11-31(17)22(33)20-21(25)29-34-28-20/h1-5,9-10,16-17H,6-8,11-13H2,(H2,25,29) UFHPCUKTTFMBQW-UHFFFAOYSA-N 532176 US11208422, Example 24::US11208422, Example 35 Potassium channel subfamily K member 9 Homo sapiens 24.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532176&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362126 463795604 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126702 Fc1ccccc1C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H25ClFN5O/c28-19-8-6-18(7-9-19)25-24(34-14-3-13-30-27(34)31-25)17-32-16-21-11-10-20(32)12-15-33(21)26(35)22-4-1-2-5-23(22)29/h1-9,13-14,20-21H,10-12,15-17H2 RDQHPRSHKJAASF-UHFFFAOYSA-N 532174 US11208422, Example 22::US11208422, Example 25 Potassium channel subfamily K member 3 Human 1100 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532174&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362137 463795602 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126703 Fc1ccccc1C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H25ClFN5O/c28-19-8-6-18(7-9-19)25-24(34-14-3-13-30-27(34)31-25)17-32-16-21-11-10-20(32)12-15-33(21)26(35)22-4-1-2-5-23(22)29/h1-9,13-14,20-21H,10-12,15-17H2 RDQHPRSHKJAASF-UHFFFAOYSA-N 532174 US11208422, Example 22::US11208422, Example 25 Potassium channel subfamily K member 9 Homo sapiens 11.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532174&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362137 463795602 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126704 COc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cc1 InChI=1S/C28H28ClN5O2/c1-36-26-7-4-5-23(30-26)28(35)33-16-14-21-12-13-22(33)17-32(21)18-24-27(19-8-10-20(29)11-9-19)31-25-6-2-3-15-34(24)25/h2-11,15,21-22H,12-14,16-18H2,1H3 ZVEHHLMWRVTKBU-UHFFFAOYSA-N 532178 US11208422, Example 26::US11208422, Example 37 Potassium channel subfamily K member 3 Human 830 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532178&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602591 463795605 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126705 COc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cc1 InChI=1S/C28H28ClN5O2/c1-36-26-7-4-5-23(30-26)28(35)33-16-14-21-12-13-22(33)17-32(21)18-24-27(19-8-10-20(29)11-9-19)31-25-6-2-3-15-34(24)25/h2-11,15,21-22H,12-14,16-18H2,1H3 ZVEHHLMWRVTKBU-UHFFFAOYSA-N 532178 US11208422, Example 26::US11208422, Example 37 Potassium channel subfamily K member 9 Homo sapiens 6.90 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532178&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602591 463795605 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126706 COc1ccc(F)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cc1 InChI=1S/C28H27ClFN5O2/c1-37-25-12-11-22(30)27(32-25)28(36)34-15-13-20-9-10-21(34)16-33(20)17-23-26(18-5-7-19(29)8-6-18)31-24-4-2-3-14-35(23)24/h2-8,11-12,14,20-21H,9-10,13,15-17H2,1H3 CBTHMJFLQJWXLC-UHFFFAOYSA-N 532179 US11208422, Example 27::US11208422, Example 38 Potassium channel subfamily K member 3 Human 150 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532179&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362220 463795606 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126707 COc1ccc(F)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cc1 InChI=1S/C28H27ClFN5O2/c1-37-25-12-11-22(30)27(32-25)28(36)34-15-13-20-9-10-21(34)16-33(20)17-23-26(18-5-7-19(29)8-6-18)31-24-4-2-3-14-35(23)24/h2-8,11-12,14,20-21H,9-10,13,15-17H2,1H3 CBTHMJFLQJWXLC-UHFFFAOYSA-N 532179 US11208422, Example 27::US11208422, Example 38 Potassium channel subfamily K member 9 Homo sapiens 3.00 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532179&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362220 463795606 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126708 COc1ccc(Cl)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cc1 InChI=1S/C28H27Cl2N5O2/c1-37-25-12-11-22(30)27(32-25)28(36)34-15-13-20-9-10-21(34)16-33(20)17-23-26(18-5-7-19(29)8-6-18)31-24-4-2-3-14-35(23)24/h2-8,11-12,14,20-21H,9-10,13,15-17H2,1H3 XQNPJKTUSODOSL-UHFFFAOYSA-N 532180 US11208422, Example 28::US11208422, Example 39 Potassium channel subfamily K member 3 Human 280 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532180&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362162 463795607 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126709 COc1ccc(Cl)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cc1 InChI=1S/C28H27Cl2N5O2/c1-37-25-12-11-22(30)27(32-25)28(36)34-15-13-20-9-10-21(34)16-33(20)17-23-26(18-5-7-19(29)8-6-18)31-24-4-2-3-14-35(23)24/h2-8,11-12,14,20-21H,9-10,13,15-17H2,1H3 XQNPJKTUSODOSL-UHFFFAOYSA-N 532180 US11208422, Example 28::US11208422, Example 39 Potassium channel subfamily K member 9 Homo sapiens 5.60 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532180&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362162 463795607 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126710 Nc1nonc1C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cc1 InChI=1S/C24H24ClN7O2/c25-16-6-4-15(5-7-16)21-19(32-11-2-1-3-20(32)27-21)14-30-13-18-9-8-17(30)10-12-31(18)24(33)22-23(26)29-34-28-22/h1-7,11,17-18H,8-10,12-14H2,(H2,26,29) WTKLDUIAXFXSFO-UHFFFAOYSA-N 532181 US11208422, Example 29::US11208422, Example 40 Potassium channel subfamily K member 3 Human 660 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532181&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602421 463795608 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126711 Nc1nonc1C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cc1 InChI=1S/C24H24ClN7O2/c25-16-6-4-15(5-7-16)21-19(32-11-2-1-3-20(32)27-21)14-30-13-18-9-8-17(30)10-12-31(18)24(33)22-23(26)29-34-28-22/h1-7,11,17-18H,8-10,12-14H2,(H2,26,29) WTKLDUIAXFXSFO-UHFFFAOYSA-N 532181 US11208422, Example 29::US11208422, Example 40 Potassium channel subfamily K member 9 Homo sapiens 4.40 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532181&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602421 463795608 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126712 Fc1ccccc1C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cn1 InChI=1S/C27H25ClFN5O/c28-18-8-11-23(30-15-18)26-24(34-13-4-3-7-25(34)31-26)17-32-16-20-10-9-19(32)12-14-33(20)27(35)21-5-1-2-6-22(21)29/h1-8,11,13,15,19-20H,9-10,12,14,16-17H2 NNIRIJTUMLYTQB-UHFFFAOYSA-N 532182 US11208422, Example 30 Potassium channel subfamily K member 3 Human 2300 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532182&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 142494549 463795609 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126713 Fc1ccccc1C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cn1 InChI=1S/C27H25ClFN5O/c28-18-8-11-23(30-15-18)26-24(34-13-4-3-7-25(34)31-26)17-32-16-20-10-9-19(32)12-14-33(20)27(35)21-5-1-2-6-22(21)29/h1-8,11,13,15,19-20H,9-10,12,14,16-17H2 NNIRIJTUMLYTQB-UHFFFAOYSA-N 532182 US11208422, Example 30 Potassium channel subfamily K member 9 Homo sapiens 220 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532182&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 142494549 463795609 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126714 Fc1ccccc1C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cn1 InChI=1S/C26H24ClFN6O/c27-17-6-9-22(30-14-17)24-23(34-12-3-11-29-26(34)31-24)16-32-15-19-8-7-18(32)10-13-33(19)25(35)20-4-1-2-5-21(20)28/h1-6,9,11-12,14,18-19H,7-8,10,13,15-16H2 KWVHCPJAJIHGFJ-UHFFFAOYSA-N 532189 US11208422, Example 31 Potassium channel subfamily K member 3 Human 910 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532189&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602592 463795616 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126715 Fc1ccccc1C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cn1 InChI=1S/C26H24ClFN6O/c27-17-6-9-22(30-14-17)24-23(34-12-3-11-29-26(34)31-24)16-32-15-19-8-7-18(32)10-13-33(19)25(35)20-4-1-2-5-21(20)28/h1-6,9,11-12,14,18-19H,7-8,10,13,15-16H2 KWVHCPJAJIHGFJ-UHFFFAOYSA-N 532189 US11208422, Example 31 Potassium channel subfamily K member 9 Homo sapiens 47.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532189&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602592 463795616 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126716 COc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H27ClN6O2/c1-36-24-5-2-4-22(30-24)26(35)33-15-12-20-10-11-21(33)16-32(20)17-23-25(18-6-8-19(28)9-7-18)31-27-29-13-3-14-34(23)27/h2-9,13-14,20-21H,10-12,15-17H2,1H3 AOLFRRHHULQGIB-UHFFFAOYSA-N 532173 US11208422, Example 21::US11208422, Example 32 Potassium channel subfamily K member 3 Human 130 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532173&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602562 463795601 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126717 COc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H27ClN6O2/c1-36-24-5-2-4-22(30-24)26(35)33-15-12-20-10-11-21(33)16-32(20)17-23-25(18-6-8-19(28)9-7-18)31-27-29-13-3-14-34(23)27/h2-9,13-14,20-21H,10-12,15-17H2,1H3 AOLFRRHHULQGIB-UHFFFAOYSA-N 532173 US11208422, Example 21::US11208422, Example 32 Potassium channel subfamily K member 9 Homo sapiens 4.10 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532173&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602562 463795601 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126718 COc1ccc(F)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H26ClFN6O2/c1-37-23-10-9-21(29)25(31-23)26(36)34-14-11-19-7-8-20(34)15-33(19)16-22-24(17-3-5-18(28)6-4-17)32-27-30-12-2-13-35(22)27/h2-6,9-10,12-13,19-20H,7-8,11,14-16H2,1H3 WXJHUHDRCAXWGL-UHFFFAOYSA-N 532169 US11208422, Example 17::US11208422, Example 33::[6-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,6-diazabicyclo[3.2.2]non-2-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 2) Potassium channel subfamily K member 3 Human 2600 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532169&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137363750 463795597 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126719 COc1ccc(F)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H26ClFN6O2/c1-37-23-10-9-21(29)25(31-23)26(36)34-14-11-19-7-8-20(34)15-33(19)16-22-24(17-3-5-18(28)6-4-17)32-27-30-12-2-13-35(22)27/h2-6,9-10,12-13,19-20H,7-8,11,14-16H2,1H3 WXJHUHDRCAXWGL-UHFFFAOYSA-N 532169 US11208422, Example 17::US11208422, Example 33::[6-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-2,6-diazabicyclo[3.2.2]non-2-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 2) Potassium channel subfamily K member 9 Homo sapiens 110 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532169&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137363750 463795597 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126720 COc1ccc(Cl)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H26Cl2N6O2/c1-37-23-10-9-21(29)25(31-23)26(36)34-14-11-19-7-8-20(34)15-33(19)16-22-24(17-3-5-18(28)6-4-17)32-27-30-12-2-13-35(22)27/h2-6,9-10,12-13,19-20H,7-8,11,14-16H2,1H3 ZCTGOWNNSZLJJU-UHFFFAOYSA-N 532175 US11208422, Example 23::US11208422, Example 34 Potassium channel subfamily K member 3 Human 4100 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532175&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362084 463795603 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126721 COc1ccc(Cl)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H26Cl2N6O2/c1-37-23-10-9-21(29)25(31-23)26(36)34-14-11-19-7-8-20(34)15-33(19)16-22-24(17-3-5-18(28)6-4-17)32-27-30-12-2-13-35(22)27/h2-6,9-10,12-13,19-20H,7-8,11,14-16H2,1H3 ZCTGOWNNSZLJJU-UHFFFAOYSA-N 532175 US11208422, Example 23::US11208422, Example 34 Potassium channel subfamily K member 9 Homo sapiens 200 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532175&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362084 463795603 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126722 Nc1nonc1C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C23H23ClN8O2/c24-15-4-2-14(3-5-15)19-18(32-10-1-9-26-23(32)27-19)13-30-12-17-7-6-16(30)8-11-31(17)22(33)20-21(25)29-34-28-20/h1-5,9-10,16-17H,6-8,11-13H2,(H2,25,29) UFHPCUKTTFMBQW-UHFFFAOYSA-N 532176 US11208422, Example 24::US11208422, Example 35 Potassium channel subfamily K member 3 Human 24000 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532176&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362126 463795604 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126723 Nc1nonc1C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C23H23ClN8O2/c24-15-4-2-14(3-5-15)19-18(32-10-1-9-26-23(32)27-19)13-30-12-17-7-6-16(30)8-11-31(17)22(33)20-21(25)29-34-28-20/h1-5,9-10,16-17H,6-8,11-13H2,(H2,25,29) UFHPCUKTTFMBQW-UHFFFAOYSA-N 532176 US11208422, Example 24::US11208422, Example 35 Potassium channel subfamily K member 9 Homo sapiens 500 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532176&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362126 463795604 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126724 Fc1ccccc1C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cc1 InChI=1S/C28H26ClFN4O/c29-20-10-8-19(9-11-20)27-25(34-15-4-3-7-26(34)31-27)18-32-17-22-13-12-21(32)14-16-33(22)28(35)23-5-1-2-6-24(23)30/h1-11,15,21-22H,12-14,16-18H2 GHVHCQGJHIWWAI-UHFFFAOYSA-N 532194 US11208422, Example 36 Potassium channel subfamily K member 3 Human 30000 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532194&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362504 463795617 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126725 Fc1ccccc1C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cc1 InChI=1S/C28H26ClFN4O/c29-20-10-8-19(9-11-20)27-25(34-15-4-3-7-26(34)31-27)18-32-17-22-13-12-21(32)14-16-33(22)28(35)23-5-1-2-6-24(23)30/h1-11,15,21-22H,12-14,16-18H2 GHVHCQGJHIWWAI-UHFFFAOYSA-N 532194 US11208422, Example 36 Potassium channel subfamily K member 9 Homo sapiens 1000 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532194&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362504 463795617 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126726 COc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cc1 InChI=1S/C28H28ClN5O2/c1-36-26-7-4-5-23(30-26)28(35)33-16-14-21-12-13-22(33)17-32(21)18-24-27(19-8-10-20(29)11-9-19)31-25-6-2-3-15-34(24)25/h2-11,15,21-22H,12-14,16-18H2,1H3 ZVEHHLMWRVTKBU-UHFFFAOYSA-N 532178 US11208422, Example 26::US11208422, Example 37 Potassium channel subfamily K member 3 Human 30000 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532178&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602591 463795605 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126727 COc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cc1 InChI=1S/C28H28ClN5O2/c1-36-26-7-4-5-23(30-26)28(35)33-16-14-21-12-13-22(33)17-32(21)18-24-27(19-8-10-20(29)11-9-19)31-25-6-2-3-15-34(24)25/h2-11,15,21-22H,12-14,16-18H2,1H3 ZVEHHLMWRVTKBU-UHFFFAOYSA-N 532178 US11208422, Example 26::US11208422, Example 37 Potassium channel subfamily K member 9 Homo sapiens 1000 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532178&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602591 463795605 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126728 COc1ccc(F)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cc1 InChI=1S/C28H27ClFN5O2/c1-37-25-12-11-22(30)27(32-25)28(36)34-15-13-20-9-10-21(34)16-33(20)17-23-26(18-5-7-19(29)8-6-18)31-24-4-2-3-14-35(23)24/h2-8,11-12,14,20-21H,9-10,13,15-17H2,1H3 CBTHMJFLQJWXLC-UHFFFAOYSA-N 532179 US11208422, Example 27::US11208422, Example 38 Potassium channel subfamily K member 3 Human 250 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532179&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362220 463795606 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126729 COc1ccc(F)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cc1 InChI=1S/C28H27ClFN5O2/c1-37-25-12-11-22(30)27(32-25)28(36)34-15-13-20-9-10-21(34)16-33(20)17-23-26(18-5-7-19(29)8-6-18)31-24-4-2-3-14-35(23)24/h2-8,11-12,14,20-21H,9-10,13,15-17H2,1H3 CBTHMJFLQJWXLC-UHFFFAOYSA-N 532179 US11208422, Example 27::US11208422, Example 38 Potassium channel subfamily K member 9 Homo sapiens 4.00 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532179&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362220 463795606 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126730 COc1ccc(Cl)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cc1 InChI=1S/C28H27Cl2N5O2/c1-37-25-12-11-22(30)27(32-25)28(36)34-15-13-20-9-10-21(34)16-33(20)17-23-26(18-5-7-19(29)8-6-18)31-24-4-2-3-14-35(23)24/h2-8,11-12,14,20-21H,9-10,13,15-17H2,1H3 XQNPJKTUSODOSL-UHFFFAOYSA-N 532180 US11208422, Example 28::US11208422, Example 39 Potassium channel subfamily K member 3 Human 370 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532180&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362162 463795607 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126731 COc1ccc(Cl)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cc1 InChI=1S/C28H27Cl2N5O2/c1-37-25-12-11-22(30)27(32-25)28(36)34-15-13-20-9-10-21(34)16-33(20)17-23-26(18-5-7-19(29)8-6-18)31-24-4-2-3-14-35(23)24/h2-8,11-12,14,20-21H,9-10,13,15-17H2,1H3 XQNPJKTUSODOSL-UHFFFAOYSA-N 532180 US11208422, Example 28::US11208422, Example 39 Potassium channel subfamily K member 9 Homo sapiens 13.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532180&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362162 463795607 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126732 Nc1nonc1C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cc1 InChI=1S/C24H24ClN7O2/c25-16-6-4-15(5-7-16)21-19(32-11-2-1-3-20(32)27-21)14-30-13-18-9-8-17(30)10-12-31(18)24(33)22-23(26)29-34-28-22/h1-7,11,17-18H,8-10,12-14H2,(H2,26,29) WTKLDUIAXFXSFO-UHFFFAOYSA-N 532181 US11208422, Example 29::US11208422, Example 40 Potassium channel subfamily K member 3 Human 3300 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532181&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602421 463795608 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126733 Nc1nonc1C(=O)N1CCC2CCC1CN2Cc1c(nc2ccccn12)-c1ccc(Cl)cc1 InChI=1S/C24H24ClN7O2/c25-16-6-4-15(5-7-16)21-19(32-11-2-1-3-20(32)27-21)14-30-13-18-9-8-17(30)10-12-31(18)24(33)22-23(26)29-34-28-22/h1-7,11,17-18H,8-10,12-14H2,(H2,26,29) WTKLDUIAXFXSFO-UHFFFAOYSA-N 532181 US11208422, Example 29::US11208422, Example 40 Potassium channel subfamily K member 9 Homo sapiens 29.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532181&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602421 463795608 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126734 COc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H34N6O2/c1-20(2)21-8-10-22(11-9-21)28-26(36-16-5-15-31-30(36)33-28)19-34-18-24-13-12-23(34)14-17-35(24)29(37)25-6-4-7-27(32-25)38-3/h4-11,15-16,20,23-24H,12-14,17-19H2,1-3H3 QQEGBOXQEVQSOP-UHFFFAOYSA-N 532199 US11208422, Example 41::US11208422, Example 48 Potassium channel subfamily K member 3 Human 2200 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532199 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532199&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 142494547 463795618 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126735 COc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H34N6O2/c1-20(2)21-8-10-22(11-9-21)28-26(36-16-5-15-31-30(36)33-28)19-34-18-24-13-12-23(34)14-17-35(24)29(37)25-6-4-7-27(32-25)38-3/h4-11,15-16,20,23-24H,12-14,17-19H2,1-3H3 QQEGBOXQEVQSOP-UHFFFAOYSA-N 532199 US11208422, Example 41::US11208422, Example 48 Potassium channel subfamily K member 9 Homo sapiens 160 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532199 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532199&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 142494547 463795618 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126736 COc1ccc(Cl)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H33ClN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(37-15-4-14-32-30(37)34-27)18-35-17-23-10-9-22(35)13-16-36(23)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 LUKLYLJQBJBXHO-UHFFFAOYSA-N 532201 US11208422, Example 43::US11208422, Example 50 Potassium channel subfamily K member 3 Human 2500 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532201&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137363732 463795620 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126737 COc1ccc(Cl)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H33ClN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(37-15-4-14-32-30(37)34-27)18-35-17-23-10-9-22(35)13-16-36(23)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 LUKLYLJQBJBXHO-UHFFFAOYSA-N 532201 US11208422, Example 43::US11208422, Example 50 Potassium channel subfamily K member 9 Homo sapiens 250 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532201&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137363732 463795620 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126738 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CCN2C(=O)c1cccc(OC(F)F)n1 InChI=1S/C30H32F2N6O2/c1-19(2)20-7-9-21(10-8-20)27-25(38-15-4-14-33-30(38)35-27)18-36-17-23-12-11-22(36)13-16-37(23)28(39)24-5-3-6-26(34-24)40-29(31)32/h3-10,14-15,19,22-23,29H,11-13,16-18H2,1-2H3 LUSIVQBGKOXLGV-UHFFFAOYSA-N 532202 US11208422, Example 45::US11208422, Example 51 Potassium channel subfamily K member 3 Human 2900 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532202&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137363715 463795621 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126739 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CCN2C(=O)c1cccc(OC(F)F)n1 InChI=1S/C30H32F2N6O2/c1-19(2)20-7-9-21(10-8-20)27-25(38-15-4-14-33-30(38)35-27)18-36-17-23-12-11-22(36)13-16-37(23)28(39)24-5-3-6-26(34-24)40-29(31)32/h3-10,14-15,19,22-23,29H,11-13,16-18H2,1-2H3 LUSIVQBGKOXLGV-UHFFFAOYSA-N 532202 US11208422, Example 45::US11208422, Example 51 Potassium channel subfamily K member 9 Homo sapiens 170 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532202&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137363715 463795621 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126740 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CCN2C(=O)c1ccccc1F InChI=1S/C30H32FN5O/c1-20(2)21-8-10-22(11-9-21)28-27(36-16-5-15-32-30(36)33-28)19-34-18-24-13-12-23(34)14-17-35(24)29(37)25-6-3-4-7-26(25)31/h3-11,15-16,20,23-24H,12-14,17-19H2,1-2H3 PIIIGFZZNAXFJA-UHFFFAOYSA-N 532203 US11208422, Example 46::US11208422, Example 47 Potassium channel subfamily K member 3 Human 16000 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532203&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602564 463795622 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126741 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CCN2C(=O)c1ccccc1F InChI=1S/C30H32FN5O/c1-20(2)21-8-10-22(11-9-21)28-27(36-16-5-15-32-30(36)33-28)19-34-18-24-13-12-23(34)14-17-35(24)29(37)25-6-3-4-7-26(25)31/h3-11,15-16,20,23-24H,12-14,17-19H2,1-2H3 PIIIGFZZNAXFJA-UHFFFAOYSA-N 532203 US11208422, Example 46::US11208422, Example 47 Potassium channel subfamily K member 9 Homo sapiens 1000 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532203&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602564 463795622 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126742 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CCN2C(=O)c1ccccc1F InChI=1S/C30H32FN5O/c1-20(2)21-8-10-22(11-9-21)28-27(36-16-5-15-32-30(36)33-28)19-34-18-24-13-12-23(34)14-17-35(24)29(37)25-6-3-4-7-26(25)31/h3-11,15-16,20,23-24H,12-14,17-19H2,1-2H3 PIIIGFZZNAXFJA-UHFFFAOYSA-N 532203 US11208422, Example 46::US11208422, Example 47 Potassium channel subfamily K member 3 Human 3100 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532203&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602564 463795622 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126743 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CCN2C(=O)c1ccccc1F InChI=1S/C30H32FN5O/c1-20(2)21-8-10-22(11-9-21)28-27(36-16-5-15-32-30(36)33-28)19-34-18-24-13-12-23(34)14-17-35(24)29(37)25-6-3-4-7-26(25)31/h3-11,15-16,20,23-24H,12-14,17-19H2,1-2H3 PIIIGFZZNAXFJA-UHFFFAOYSA-N 532203 US11208422, Example 46::US11208422, Example 47 Potassium channel subfamily K member 9 Homo sapiens 180 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532203&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602564 463795622 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126744 COc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H34N6O2/c1-20(2)21-8-10-22(11-9-21)28-26(36-16-5-15-31-30(36)33-28)19-34-18-24-13-12-23(34)14-17-35(24)29(37)25-6-4-7-27(32-25)38-3/h4-11,15-16,20,23-24H,12-14,17-19H2,1-3H3 QQEGBOXQEVQSOP-UHFFFAOYSA-N 532199 US11208422, Example 41::US11208422, Example 48 Potassium channel subfamily K member 3 Human 12000 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532199 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532199&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 142494547 463795618 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126745 COc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H34N6O2/c1-20(2)21-8-10-22(11-9-21)28-26(36-16-5-15-31-30(36)33-28)19-34-18-24-13-12-23(34)14-17-35(24)29(37)25-6-4-7-27(32-25)38-3/h4-11,15-16,20,23-24H,12-14,17-19H2,1-3H3 QQEGBOXQEVQSOP-UHFFFAOYSA-N 532199 US11208422, Example 41::US11208422, Example 48 Potassium channel subfamily K member 9 Homo sapiens 430 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532199 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532199&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 142494547 463795618 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126746 COc1ccc(F)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H33FN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(37-15-4-14-32-30(37)34-27)18-35-17-23-10-9-22(35)13-16-36(23)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 YMEOGTVUHUVTDA-UHFFFAOYSA-N 532207 US11208422, Example 49 Potassium channel subfamily K member 3 Human 5500 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532207&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362131 463795624 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126747 COc1ccc(F)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H33FN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(37-15-4-14-32-30(37)34-27)18-35-17-23-10-9-22(35)13-16-36(23)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 YMEOGTVUHUVTDA-UHFFFAOYSA-N 532207 US11208422, Example 49 Potassium channel subfamily K member 9 Homo sapiens 540 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532207&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362131 463795624 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126748 COc1ccc(Cl)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H33ClN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(37-15-4-14-32-30(37)34-27)18-35-17-23-10-9-22(35)13-16-36(23)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 LUKLYLJQBJBXHO-UHFFFAOYSA-N 532201 US11208422, Example 43::US11208422, Example 50 Potassium channel subfamily K member 3 Human 2500 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532201&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137363732 463795620 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126749 COc1ccc(Cl)c(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H33ClN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(37-15-4-14-32-30(37)34-27)18-35-17-23-10-9-22(35)13-16-36(23)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 LUKLYLJQBJBXHO-UHFFFAOYSA-N 532201 US11208422, Example 43::US11208422, Example 50 Potassium channel subfamily K member 9 Homo sapiens 440 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532201&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137363732 463795620 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126750 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CCN2C(=O)c1cccc(OC(F)F)n1 InChI=1S/C30H32F2N6O2/c1-19(2)20-7-9-21(10-8-20)27-25(38-15-4-14-33-30(38)35-27)18-36-17-23-12-11-22(36)13-16-37(23)28(39)24-5-3-6-26(34-24)40-29(31)32/h3-10,14-15,19,22-23,29H,11-13,16-18H2,1-2H3 LUSIVQBGKOXLGV-UHFFFAOYSA-N 532202 US11208422, Example 45::US11208422, Example 51 Potassium channel subfamily K member 3 Human 1100 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532202&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137363715 463795621 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126751 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CCN2C(=O)c1cccc(OC(F)F)n1 InChI=1S/C30H32F2N6O2/c1-19(2)20-7-9-21(10-8-20)27-25(38-15-4-14-33-30(38)35-27)18-36-17-23-12-11-22(36)13-16-37(23)28(39)24-5-3-6-26(34-24)40-29(31)32/h3-10,14-15,19,22-23,29H,11-13,16-18H2,1-2H3 LUSIVQBGKOXLGV-UHFFFAOYSA-N 532202 US11208422, Example 45::US11208422, Example 51 Potassium channel subfamily K member 9 Homo sapiens 110 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532202&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137363715 463795621 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126752 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CCN2C(=O)C1CCCC1 InChI=1S/C29H37N5O/c1-20(2)21-8-10-22(11-9-21)27-26(34-16-5-15-30-29(34)31-27)19-32-18-25-13-12-24(32)14-17-33(25)28(35)23-6-3-4-7-23/h5,8-11,15-16,20,23-25H,3-4,6-7,12-14,17-19H2,1-2H3 GUGDPBMDLBPURJ-UHFFFAOYSA-N 532210 US11208422, Example 52 Potassium channel subfamily K member 3 Human 3800 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532210&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 142494588 463795625 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126753 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1CC2CCC1CCN2C(=O)C1CCCC1 InChI=1S/C29H37N5O/c1-20(2)21-8-10-22(11-9-21)27-26(34-16-5-15-30-29(34)31-27)19-32-18-25-13-12-24(32)14-17-33(25)28(35)23-6-3-4-7-23/h5,8-11,15-16,20,23-25H,3-4,6-7,12-14,17-19H2,1-2H3 GUGDPBMDLBPURJ-UHFFFAOYSA-N 532210 US11208422, Example 52 Potassium channel subfamily K member 9 Homo sapiens 140 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532210&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 142494588 463795625 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126754 COc1ccc(F)c(n1)C(=O)N1CCC2CCC(C1)N2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H33FN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(36-15-4-14-32-30(36)34-27)18-37-22-9-10-23(37)17-35(16-13-22)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 ROSYITDNZIDSDA-UHFFFAOYSA-N 532212 US11208422, Example 53::US11208422, Example 58 Potassium channel subfamily K member 3 Human 1300 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532212&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 142494590 463795627 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126755 COc1ccc(F)c(n1)C(=O)N1CCC2CCC(C1)N2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H33FN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(36-15-4-14-32-30(36)34-27)18-37-22-9-10-23(37)17-35(16-13-22)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 ROSYITDNZIDSDA-UHFFFAOYSA-N 532212 US11208422, Example 53::US11208422, Example 58 Potassium channel subfamily K member 9 Homo sapiens 380 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532212&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 142494590 463795627 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126756 COc1ccc(Cl)c(n1)C(=O)N1CCC2CCC(C1)N2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H33ClN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(36-15-4-14-32-30(36)34-27)18-37-22-9-10-23(37)17-35(16-13-22)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 BSSIHKNXWKVEMG-UHFFFAOYSA-N 532213 US11208422, Example 54::US11208422, Example 59 Potassium channel subfamily K member 3 Human 780 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532213 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532213&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 142494551 463795628 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126757 COc1ccc(Cl)c(n1)C(=O)N1CCC2CCC(C1)N2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H33ClN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(36-15-4-14-32-30(36)34-27)18-37-22-9-10-23(37)17-35(16-13-22)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 BSSIHKNXWKVEMG-UHFFFAOYSA-N 532213 US11208422, Example 54::US11208422, Example 59 Potassium channel subfamily K member 9 Homo sapiens 290 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532213 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532213&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 142494551 463795628 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126758 COc1cccc(n1)C(=O)N1CCC2CCC(C1)N2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H34N6O2/c1-20(2)21-8-10-22(11-9-21)28-26(35-16-5-15-31-30(35)33-28)19-36-23-12-13-24(36)18-34(17-14-23)29(37)25-6-4-7-27(32-25)38-3/h4-11,15-16,20,23-24H,12-14,17-19H2,1-3H3 SZZKGUCBYNHTJO-UHFFFAOYSA-N 532214 US11208422, Example 55::US11208422, Example 60 Potassium channel subfamily K member 3 Human 4000 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532214&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362083 463795629 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126759 COc1cccc(n1)C(=O)N1CCC2CCC(C1)N2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H34N6O2/c1-20(2)21-8-10-22(11-9-21)28-26(35-16-5-15-31-30(35)33-28)19-36-23-12-13-24(36)18-34(17-14-23)29(37)25-6-4-7-27(32-25)38-3/h4-11,15-16,20,23-24H,12-14,17-19H2,1-3H3 SZZKGUCBYNHTJO-UHFFFAOYSA-N 532214 US11208422, Example 55::US11208422, Example 60 Potassium channel subfamily K member 9 Homo sapiens 1000 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532214&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362083 463795629 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126760 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1C2CCC1CN(CC2)C(=O)c1cccc(OC(F)F)n1 InChI=1S/C30H32F2N6O2/c1-19(2)20-7-9-21(10-8-20)27-25(37-15-4-14-33-30(37)35-27)18-38-22-11-12-23(38)17-36(16-13-22)28(39)24-5-3-6-26(34-24)40-29(31)32/h3-10,14-15,19,22-23,29H,11-13,16-18H2,1-2H3 LTVCAWFRKQEWAU-UHFFFAOYSA-N 532215 US11208422, Example 56::US11208422, Example 61 Potassium channel subfamily K member 3 Human 8500 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532215&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602595 463795630 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126761 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1C2CCC1CN(CC2)C(=O)c1cccc(OC(F)F)n1 InChI=1S/C30H32F2N6O2/c1-19(2)20-7-9-21(10-8-20)27-25(37-15-4-14-33-30(37)35-27)18-38-22-11-12-23(38)17-36(16-13-22)28(39)24-5-3-6-26(34-24)40-29(31)32/h3-10,14-15,19,22-23,29H,11-13,16-18H2,1-2H3 LTVCAWFRKQEWAU-UHFFFAOYSA-N 532215 US11208422, Example 56::US11208422, Example 61 Potassium channel subfamily K member 9 Homo sapiens 1000 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532215&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602595 463795630 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126762 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1C2CCC1CN(CC2)C(=O)C1CCCC1 InChI=1S/C29H37N5O/c1-20(2)21-8-10-22(11-9-21)27-26(33-16-5-15-30-29(33)31-27)19-34-24-12-13-25(34)18-32(17-14-24)28(35)23-6-3-4-7-23/h5,8-11,15-16,20,23-25H,3-4,6-7,12-14,17-19H2,1-2H3 YTLXFOBPUWCZRL-UHFFFAOYSA-N 532216 US11208422, Example 57::US11208422, Example 62 Potassium channel subfamily K member 3 Human 6200 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532216&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 142494563 463795631 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126763 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1C2CCC1CN(CC2)C(=O)C1CCCC1 InChI=1S/C29H37N5O/c1-20(2)21-8-10-22(11-9-21)27-26(33-16-5-15-30-29(33)31-27)19-34-24-12-13-25(34)18-32(17-14-24)28(35)23-6-3-4-7-23/h5,8-11,15-16,20,23-25H,3-4,6-7,12-14,17-19H2,1-2H3 YTLXFOBPUWCZRL-UHFFFAOYSA-N 532216 US11208422, Example 57::US11208422, Example 62 Potassium channel subfamily K member 9 Homo sapiens 2000 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532216&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 142494563 463795631 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126764 COc1ccc(F)c(n1)C(=O)N1CCC2CCC(C1)N2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H33FN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(36-15-4-14-32-30(36)34-27)18-37-22-9-10-23(37)17-35(16-13-22)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 ROSYITDNZIDSDA-UHFFFAOYSA-N 532212 US11208422, Example 53::US11208422, Example 58 Potassium channel subfamily K member 3 Human 2900 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532212&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 142494590 463795627 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126765 COc1ccc(F)c(n1)C(=O)N1CCC2CCC(C1)N2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H33FN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(36-15-4-14-32-30(36)34-27)18-37-22-9-10-23(37)17-35(16-13-22)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 ROSYITDNZIDSDA-UHFFFAOYSA-N 532212 US11208422, Example 53::US11208422, Example 58 Potassium channel subfamily K member 9 Homo sapiens 920 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532212&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 142494590 463795627 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126766 COc1ccc(Cl)c(n1)C(=O)N1CCC2CCC(C1)N2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H33ClN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(36-15-4-14-32-30(36)34-27)18-37-22-9-10-23(37)17-35(16-13-22)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 BSSIHKNXWKVEMG-UHFFFAOYSA-N 532213 US11208422, Example 54::US11208422, Example 59 Potassium channel subfamily K member 3 Human 1100 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532213 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532213&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 142494551 463795628 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126767 COc1ccc(Cl)c(n1)C(=O)N1CCC2CCC(C1)N2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H33ClN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(36-15-4-14-32-30(36)34-27)18-37-22-9-10-23(37)17-35(16-13-22)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 BSSIHKNXWKVEMG-UHFFFAOYSA-N 532213 US11208422, Example 54::US11208422, Example 59 Potassium channel subfamily K member 9 Homo sapiens 680 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532213 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532213&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 142494551 463795628 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126768 COc1cccc(n1)C(=O)N1CCC2CCC(C1)N2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H34N6O2/c1-20(2)21-8-10-22(11-9-21)28-26(35-16-5-15-31-30(35)33-28)19-36-23-12-13-24(36)18-34(17-14-23)29(37)25-6-4-7-27(32-25)38-3/h4-11,15-16,20,23-24H,12-14,17-19H2,1-3H3 SZZKGUCBYNHTJO-UHFFFAOYSA-N 532214 US11208422, Example 55::US11208422, Example 60 Potassium channel subfamily K member 3 Human 5200 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532214&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362083 463795629 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126769 COc1cccc(n1)C(=O)N1CCC2CCC(C1)N2Cc1c(nc2ncccn12)-c1ccc(cc1)C(C)C InChI=1S/C30H34N6O2/c1-20(2)21-8-10-22(11-9-21)28-26(35-16-5-15-31-30(35)33-28)19-36-23-12-13-24(36)18-34(17-14-23)29(37)25-6-4-7-27(32-25)38-3/h4-11,15-16,20,23-24H,12-14,17-19H2,1-3H3 SZZKGUCBYNHTJO-UHFFFAOYSA-N 532214 US11208422, Example 55::US11208422, Example 60 Potassium channel subfamily K member 9 Homo sapiens 1000 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532214&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362083 463795629 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126770 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1C2CCC1CN(CC2)C(=O)c1cccc(OC(F)F)n1 InChI=1S/C30H32F2N6O2/c1-19(2)20-7-9-21(10-8-20)27-25(37-15-4-14-33-30(37)35-27)18-38-22-11-12-23(38)17-36(16-13-22)28(39)24-5-3-6-26(34-24)40-29(31)32/h3-10,14-15,19,22-23,29H,11-13,16-18H2,1-2H3 LTVCAWFRKQEWAU-UHFFFAOYSA-N 532215 US11208422, Example 56::US11208422, Example 61 Potassium channel subfamily K member 3 Human 9400 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532215&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602595 463795630 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126771 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1C2CCC1CN(CC2)C(=O)c1cccc(OC(F)F)n1 InChI=1S/C30H32F2N6O2/c1-19(2)20-7-9-21(10-8-20)27-25(37-15-4-14-33-30(37)35-27)18-38-22-11-12-23(38)17-36(16-13-22)28(39)24-5-3-6-26(34-24)40-29(31)32/h3-10,14-15,19,22-23,29H,11-13,16-18H2,1-2H3 LTVCAWFRKQEWAU-UHFFFAOYSA-N 532215 US11208422, Example 56::US11208422, Example 61 Potassium channel subfamily K member 9 Homo sapiens 1000 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532215&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602595 463795630 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126772 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1C2CCC1CN(CC2)C(=O)C1CCCC1 InChI=1S/C29H37N5O/c1-20(2)21-8-10-22(11-9-21)27-26(33-16-5-15-30-29(33)31-27)19-34-24-12-13-25(34)18-32(17-14-24)28(35)23-6-3-4-7-23/h5,8-11,15-16,20,23-25H,3-4,6-7,12-14,17-19H2,1-2H3 YTLXFOBPUWCZRL-UHFFFAOYSA-N 532216 US11208422, Example 57::US11208422, Example 62 Potassium channel subfamily K member 3 Human 8400 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532216&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 142494563 463795631 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126773 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1C2CCC1CN(CC2)C(=O)C1CCCC1 InChI=1S/C29H37N5O/c1-20(2)21-8-10-22(11-9-21)27-26(33-16-5-15-30-29(33)31-27)19-34-24-12-13-25(34)18-32(17-14-24)28(35)23-6-3-4-7-23/h5,8-11,15-16,20,23-25H,3-4,6-7,12-14,17-19H2,1-2H3 YTLXFOBPUWCZRL-UHFFFAOYSA-N 532216 US11208422, Example 57::US11208422, Example 62 Potassium channel subfamily K member 9 Homo sapiens 1000 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532216&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 142494563 463795631 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126774 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1C2CCC1CN(CC2)C(=O)c1ccccc1F InChI=1S/C30H32FN5O/c1-20(2)21-8-10-22(11-9-21)28-27(35-16-5-15-32-30(35)33-28)19-36-23-12-13-24(36)18-34(17-14-23)29(37)25-6-3-4-7-26(25)31/h3-11,15-16,20,23-24H,12-14,17-19H2,1-2H3 RYFIOJQQPUATAL-UHFFFAOYSA-N 532222 US11208422, Example 63::US11208422, Example 64 Potassium channel subfamily K member 3 Human 8400 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532222&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137361850 463795632 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126775 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1C2CCC1CN(CC2)C(=O)c1ccccc1F InChI=1S/C30H32FN5O/c1-20(2)21-8-10-22(11-9-21)28-27(35-16-5-15-32-30(35)33-28)19-36-23-12-13-24(36)18-34(17-14-23)29(37)25-6-3-4-7-26(25)31/h3-11,15-16,20,23-24H,12-14,17-19H2,1-2H3 RYFIOJQQPUATAL-UHFFFAOYSA-N 532222 US11208422, Example 63::US11208422, Example 64 Potassium channel subfamily K member 9 Homo sapiens 800 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532222&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137361850 463795632 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126776 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1C2CCC1CN(CC2)C(=O)c1ccccc1F InChI=1S/C30H32FN5O/c1-20(2)21-8-10-22(11-9-21)28-27(35-16-5-15-32-30(35)33-28)19-36-23-12-13-24(36)18-34(17-14-23)29(37)25-6-3-4-7-26(25)31/h3-11,15-16,20,23-24H,12-14,17-19H2,1-2H3 RYFIOJQQPUATAL-UHFFFAOYSA-N 532222 US11208422, Example 63::US11208422, Example 64 Potassium channel subfamily K member 3 Human 7200 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532222&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137361850 463795632 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126777 CC(C)c1ccc(cc1)-c1nc2ncccn2c1CN1C2CCC1CN(CC2)C(=O)c1ccccc1F InChI=1S/C30H32FN5O/c1-20(2)21-8-10-22(11-9-21)28-27(35-16-5-15-32-30(35)33-28)19-36-23-12-13-24(36)18-34(17-14-23)29(37)25-6-3-4-7-26(25)31/h3-11,15-16,20,23-24H,12-14,17-19H2,1-2H3 RYFIOJQQPUATAL-UHFFFAOYSA-N 532222 US11208422, Example 63::US11208422, Example 64 Potassium channel subfamily K member 9 Homo sapiens 1800 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532222&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137361850 463795632 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126778 FC(F)(F)Oc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H24ClF3N6O2/c28-18-7-5-17(6-8-18)24-22(37-13-2-12-32-26(37)34-24)16-35-15-20-10-9-19(35)11-14-36(20)25(38)21-3-1-4-23(33-21)39-27(29,30)31/h1-8,12-13,19-20H,9-11,14-16H2 HLBRSQTXTRUYSW-UHFFFAOYSA-N 532224 US11208422, Example 65::US11208422, Example 66 Potassium channel subfamily K member 3 Human 1400 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532224 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532224&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602415 463795633 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126779 FC(F)(F)Oc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H24ClF3N6O2/c28-18-7-5-17(6-8-18)24-22(37-13-2-12-32-26(37)34-24)16-35-15-20-10-9-19(35)11-14-36(20)25(38)21-3-1-4-23(33-21)39-27(29,30)31/h1-8,12-13,19-20H,9-11,14-16H2 HLBRSQTXTRUYSW-UHFFFAOYSA-N 532224 US11208422, Example 65::US11208422, Example 66 Potassium channel subfamily K member 9 Homo sapiens 220 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532224 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532224&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602415 463795633 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126780 FC(F)(F)Oc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H24ClF3N6O2/c28-18-7-5-17(6-8-18)24-22(37-13-2-12-32-26(37)34-24)16-35-15-20-10-9-19(35)11-14-36(20)25(38)21-3-1-4-23(33-21)39-27(29,30)31/h1-8,12-13,19-20H,9-11,14-16H2 HLBRSQTXTRUYSW-UHFFFAOYSA-N 532224 US11208422, Example 65::US11208422, Example 66 Potassium channel subfamily K member 3 Human 180 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532224 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532224&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602415 463795633 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126781 FC(F)(F)Oc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H24ClF3N6O2/c28-18-7-5-17(6-8-18)24-22(37-13-2-12-32-26(37)34-24)16-35-15-20-10-9-19(35)11-14-36(20)25(38)21-3-1-4-23(33-21)39-27(29,30)31/h1-8,12-13,19-20H,9-11,14-16H2 HLBRSQTXTRUYSW-UHFFFAOYSA-N 532224 US11208422, Example 65::US11208422, Example 66 Potassium channel subfamily K member 9 Homo sapiens 19.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532224 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532224&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602415 463795633 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126782 FC(F)Oc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H25ClF2N6O2/c28-18-7-5-17(6-8-18)24-22(36-13-2-12-31-27(36)33-24)16-34-15-20-10-9-19(34)11-14-35(20)25(37)21-3-1-4-23(32-21)38-26(29)30/h1-8,12-13,19-20,26H,9-11,14-16H2 IOPDSLXHYAIRFH-UHFFFAOYSA-N 532226 US11208422, Example 67::US11208422, Example 68 Potassium channel subfamily K member 3 Human 3400 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532226&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602511 463795634 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126783 FC(F)Oc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H25ClF2N6O2/c28-18-7-5-17(6-8-18)24-22(36-13-2-12-31-27(36)33-24)16-34-15-20-10-9-19(34)11-14-35(20)25(37)21-3-1-4-23(32-21)38-26(29)30/h1-8,12-13,19-20,26H,9-11,14-16H2 IOPDSLXHYAIRFH-UHFFFAOYSA-N 532226 US11208422, Example 67::US11208422, Example 68 Potassium channel subfamily K member 9 Homo sapiens 370 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532226&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602511 463795634 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126784 FC(F)Oc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H25ClF2N6O2/c28-18-7-5-17(6-8-18)24-22(36-13-2-12-31-27(36)33-24)16-34-15-20-10-9-19(34)11-14-35(20)25(37)21-3-1-4-23(32-21)38-26(29)30/h1-8,12-13,19-20,26H,9-11,14-16H2 IOPDSLXHYAIRFH-UHFFFAOYSA-N 532226 US11208422, Example 67::US11208422, Example 68 Potassium channel subfamily K member 3 Human 230 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532226&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602511 463795634 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126785 FC(F)Oc1cccc(n1)C(=O)N1CCC2CCC1CN2Cc1c(nc2ncccn12)-c1ccc(Cl)cc1 InChI=1S/C27H25ClF2N6O2/c28-18-7-5-17(6-8-18)24-22(36-13-2-12-31-27(36)33-24)16-34-15-20-10-9-19(34)11-14-35(20)25(37)21-3-1-4-23(32-21)38-26(29)30/h1-8,12-13,19-20,26H,9-11,14-16H2 IOPDSLXHYAIRFH-UHFFFAOYSA-N 532226 US11208422, Example 67::US11208422, Example 68 Potassium channel subfamily K member 9 Homo sapiens 31.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532226&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602511 463795634 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126786 Fc1ccccc1C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H26ClFN4O/c29-20-10-8-19(9-11-20)27-25(33-15-4-3-7-26(33)31-27)18-32-16-14-21-12-13-22(17-32)34(21)28(35)23-5-1-2-6-24(23)30/h1-11,15,21-22H,12-14,16-18H2 WKFGLINXRSPXAG-UHFFFAOYSA-N 532228 US11208422, Example 69::US11208422, Example 88::US11208422, Example 89 Potassium channel subfamily K member 3 Human 1400 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532228&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362230 463795635 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126787 Fc1ccccc1C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H26ClFN4O/c29-20-10-8-19(9-11-20)27-25(33-15-4-3-7-26(33)31-27)18-32-16-14-21-12-13-22(17-32)34(21)28(35)23-5-1-2-6-24(23)30/h1-11,15,21-22H,12-14,16-18H2 WKFGLINXRSPXAG-UHFFFAOYSA-N 532228 US11208422, Example 69::US11208422, Example 88::US11208422, Example 89 Potassium channel subfamily K member 9 Homo sapiens 62.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532228&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362230 463795635 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126788 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H28ClN5O2/c1-36-26-7-4-5-23(30-26)28(35)34-21-12-13-22(34)17-32(16-14-21)18-24-27(19-8-10-20(29)11-9-19)31-25-6-2-3-15-33(24)25/h2-11,15,21-22H,12-14,16-18H2,1H3 BAEIXOAVLHXXML-UHFFFAOYSA-N 532229 US11208422, Example 70::US11208422, Example 90::US11208422, Example 91 Potassium channel subfamily K member 3 Human 305 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532229 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532229&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362165 463795636 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126789 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H28ClN5O2/c1-36-26-7-4-5-23(30-26)28(35)34-21-12-13-22(34)17-32(16-14-21)18-24-27(19-8-10-20(29)11-9-19)31-25-6-2-3-15-33(24)25/h2-11,15,21-22H,12-14,16-18H2,1H3 BAEIXOAVLHXXML-UHFFFAOYSA-N 532229 US11208422, Example 70::US11208422, Example 90::US11208422, Example 91 Potassium channel subfamily K member 9 Homo sapiens 4.70 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532229 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532229&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362165 463795636 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126790 Fc1ccccc1C(=O)N1C2COCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H26ClFN4O2/c29-20-10-8-19(9-11-20)27-25(33-13-4-3-7-26(33)31-27)16-32-14-12-21-17-36-18-22(15-32)34(21)28(35)23-5-1-2-6-24(23)30/h1-11,13,21-22H,12,14-18H2 WZMKJFLQCVIPJH-UHFFFAOYSA-N 532230 US11208422, Example 71 Potassium channel subfamily K member 3 Human 740 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532230 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532230&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602420 463795637 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126791 Fc1ccccc1C(=O)N1C2COCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H26ClFN4O2/c29-20-10-8-19(9-11-20)27-25(33-13-4-3-7-26(33)31-27)16-32-14-12-21-17-36-18-22(15-32)34(21)28(35)23-5-1-2-6-24(23)30/h1-11,13,21-22H,12,14-18H2 WZMKJFLQCVIPJH-UHFFFAOYSA-N 532230 US11208422, Example 71 Potassium channel subfamily K member 9 Homo sapiens 31.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532230 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532230&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602420 463795637 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126792 COc1cccc(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H28ClN5O3/c1-36-26-7-4-5-23(30-26)28(35)34-21-12-14-32(15-22(34)18-37-17-21)16-24-27(19-8-10-20(29)11-9-19)31-25-6-2-3-13-33(24)25/h2-11,13,21-22H,12,14-18H2,1H3 HODAOGYGYCRTOZ-UHFFFAOYSA-N 532231 US11208422, Example 72 Potassium channel subfamily K member 3 Human 120 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532231&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362942 463795638 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126793 COc1cccc(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H28ClN5O3/c1-36-26-7-4-5-23(30-26)28(35)34-21-12-14-32(15-22(34)18-37-17-21)16-24-27(19-8-10-20(29)11-9-19)31-25-6-2-3-13-33(24)25/h2-11,13,21-22H,12,14-18H2,1H3 HODAOGYGYCRTOZ-UHFFFAOYSA-N 532231 US11208422, Example 72 Potassium channel subfamily K member 9 Homo sapiens 5.10 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532231&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362942 463795638 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126794 Cc1nonc1C(=O)N1C2COCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C25H25ClN6O3/c1-16-23(29-35-28-16)25(33)32-19-9-11-30(12-20(32)15-34-14-19)13-21-24(17-5-7-18(26)8-6-17)27-22-4-2-3-10-31(21)22/h2-8,10,19-20H,9,11-15H2,1H3 VXPWRCPIZSFFFR-UHFFFAOYSA-N 532232 US11208422, Example 73 Potassium channel subfamily K member 3 Human 99.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532232&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362142 463795639 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126795 Cc1nonc1C(=O)N1C2COCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C25H25ClN6O3/c1-16-23(29-35-28-16)25(33)32-19-9-11-30(12-20(32)15-34-14-19)13-21-24(17-5-7-18(26)8-6-17)27-22-4-2-3-10-31(21)22/h2-8,10,19-20H,9,11-15H2,1H3 VXPWRCPIZSFFFR-UHFFFAOYSA-N 532232 US11208422, Example 73 Potassium channel subfamily K member 9 Homo sapiens 5.00 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532232&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362142 463795639 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126796 Fc1ccccc1C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H25ClFN5O2/c28-19-8-6-18(7-9-19)25-24(33-12-3-11-30-27(33)31-25)15-32-13-10-20-16-36-17-21(14-32)34(20)26(35)22-4-1-2-5-23(22)29/h1-9,11-12,20-21H,10,13-17H2 VNAPLFJGZRRINX-UHFFFAOYSA-N 532233 US11208422, Example 74 Potassium channel subfamily K member 3 Human 5000 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532233 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532233&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602594 463795640 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126797 Fc1ccccc1C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H25ClFN5O2/c28-19-8-6-18(7-9-19)25-24(33-12-3-11-30-27(33)31-25)15-32-13-10-20-16-36-17-21(14-32)34(20)26(35)22-4-1-2-5-23(22)29/h1-9,11-12,20-21H,10,13-17H2 VNAPLFJGZRRINX-UHFFFAOYSA-N 532233 US11208422, Example 74 Potassium channel subfamily K member 9 Homo sapiens 200 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532233 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532233&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602594 463795640 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126798 COc1cccc(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H27ClN6O3/c1-36-24-5-2-4-22(30-24)26(35)34-20-10-13-32(14-21(34)17-37-16-20)15-23-25(18-6-8-19(28)9-7-18)31-27-29-11-3-12-33(23)27/h2-9,11-12,20-21H,10,13-17H2,1H3 MUVMSFXUSZIZFZ-UHFFFAOYSA-N 532234 US11208422, Example 75 Potassium channel subfamily K member 3 Human 2300 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532234&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602502 463795641 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126799 COc1cccc(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H27ClN6O3/c1-36-24-5-2-4-22(30-24)26(35)34-20-10-13-32(14-21(34)17-37-16-20)15-23-25(18-6-8-19(28)9-7-18)31-27-29-11-3-12-33(23)27/h2-9,11-12,20-21H,10,13-17H2,1H3 MUVMSFXUSZIZFZ-UHFFFAOYSA-N 532234 US11208422, Example 75 Potassium channel subfamily K member 9 Homo sapiens 77.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532234&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602502 463795641 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126800 Cc1nonc1C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C24H24ClN7O3/c1-15-21(29-35-28-15)23(33)32-18-7-10-30(11-19(32)14-34-13-18)12-20-22(16-3-5-17(25)6-4-16)27-24-26-8-2-9-31(20)24/h2-6,8-9,18-19H,7,10-14H2,1H3 JTCQHXOOGSLWFL-UHFFFAOYSA-N 532235 US11208422, Example 76 Potassium channel subfamily K member 3 Human 1400 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532235&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602424 463795642 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126801 Cc1nonc1C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C24H24ClN7O3/c1-15-21(29-35-28-15)23(33)32-18-7-10-30(11-19(32)14-34-13-18)12-20-22(16-3-5-17(25)6-4-16)27-24-26-8-2-9-31(20)24/h2-6,8-9,18-19H,7,10-14H2,1H3 JTCQHXOOGSLWFL-UHFFFAOYSA-N 532235 US11208422, Example 76 Potassium channel subfamily K member 9 Homo sapiens 66.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532235&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602424 463795642 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126802 Nc1nonc1C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C23H23ClN8O3/c24-15-4-2-14(3-5-15)19-18(31-8-1-7-26-23(31)27-19)11-30-9-6-16-12-34-13-17(10-30)32(16)22(33)20-21(25)29-35-28-20/h1-5,7-8,16-17H,6,9-13H2,(H2,25,29) KNOQMYMONBWKJG-UHFFFAOYSA-N 532236 US11208422, Example 77 Potassium channel subfamily K member 3 Human 3300 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532236 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532236&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137363452 463795643 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126803 Nc1nonc1C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C23H23ClN8O3/c24-15-4-2-14(3-5-15)19-18(31-8-1-7-26-23(31)27-19)11-30-9-6-16-12-34-13-17(10-30)32(16)22(33)20-21(25)29-35-28-20/h1-5,7-8,16-17H,6,9-13H2,(H2,25,29) KNOQMYMONBWKJG-UHFFFAOYSA-N 532236 US11208422, Example 77 Potassium channel subfamily K member 9 Homo sapiens 270 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532236 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532236&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137363452 463795643 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126804 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H27ClFN5O2/c1-37-25-12-11-22(30)27(32-25)28(36)35-20-9-10-21(35)16-33(15-13-20)17-23-26(18-5-7-19(29)8-6-18)31-24-4-2-3-14-34(23)24/h2-8,11-12,14,20-21H,9-10,13,15-17H2,1H3 CDUFDBMSBRUMBD-UHFFFAOYSA-N 532237 US11208422, Example 78::US11208422, Example 79 Potassium channel subfamily K member 3 Human 220 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532237 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532237&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362159 463795644 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126805 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H27ClFN5O2/c1-37-25-12-11-22(30)27(32-25)28(36)35-20-9-10-21(35)16-33(15-13-20)17-23-26(18-5-7-19(29)8-6-18)31-24-4-2-3-14-34(23)24/h2-8,11-12,14,20-21H,9-10,13,15-17H2,1H3 CDUFDBMSBRUMBD-UHFFFAOYSA-N 532237 US11208422, Example 78::US11208422, Example 79 Potassium channel subfamily K member 9 Homo sapiens 5.00 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532237 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532237&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362159 463795644 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126806 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H27ClFN5O2/c1-37-25-12-11-22(30)27(32-25)28(36)35-20-9-10-21(35)16-33(15-13-20)17-23-26(18-5-7-19(29)8-6-18)31-24-4-2-3-14-34(23)24/h2-8,11-12,14,20-21H,9-10,13,15-17H2,1H3 CDUFDBMSBRUMBD-UHFFFAOYSA-N 532237 US11208422, Example 78::US11208422, Example 79 Potassium channel subfamily K member 3 Human 290 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532237 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532237&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362159 463795644 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126807 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H27ClFN5O2/c1-37-25-12-11-22(30)27(32-25)28(36)35-20-9-10-21(35)16-33(15-13-20)17-23-26(18-5-7-19(29)8-6-18)31-24-4-2-3-14-34(23)24/h2-8,11-12,14,20-21H,9-10,13,15-17H2,1H3 CDUFDBMSBRUMBD-UHFFFAOYSA-N 532237 US11208422, Example 78::US11208422, Example 79 Potassium channel subfamily K member 9 Homo sapiens 11.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532237 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532237&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362159 463795644 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126808 Fc1ccccc1C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H25ClFN5O/c28-19-8-6-18(7-9-19)25-24(33-14-3-13-30-27(33)31-25)17-32-15-12-20-10-11-21(16-32)34(20)26(35)22-4-1-2-5-23(22)29/h1-9,13-14,20-21H,10-12,15-17H2 CMZQGKVDTVUQLY-UHFFFAOYSA-N 532239 US11208422, Example 80::US11208422, Example 81 Potassium channel subfamily K member 3 Human 4500 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532239&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362158 463795645 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126809 Fc1ccccc1C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H25ClFN5O/c28-19-8-6-18(7-9-19)25-24(33-14-3-13-30-27(33)31-25)17-32-15-12-20-10-11-21(16-32)34(20)26(35)22-4-1-2-5-23(22)29/h1-9,13-14,20-21H,10-12,15-17H2 CMZQGKVDTVUQLY-UHFFFAOYSA-N 532239 US11208422, Example 80::US11208422, Example 81 Potassium channel subfamily K member 9 Homo sapiens 93.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532239&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362158 463795645 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126810 Fc1ccccc1C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H25ClFN5O/c28-19-8-6-18(7-9-19)25-24(33-14-3-13-30-27(33)31-25)17-32-15-12-20-10-11-21(16-32)34(20)26(35)22-4-1-2-5-23(22)29/h1-9,13-14,20-21H,10-12,15-17H2 CMZQGKVDTVUQLY-UHFFFAOYSA-N 532239 US11208422, Example 80::US11208422, Example 81 Potassium channel subfamily K member 3 Human 590 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532239&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362158 463795645 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126811 Fc1ccccc1C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H25ClFN5O/c28-19-8-6-18(7-9-19)25-24(33-14-3-13-30-27(33)31-25)17-32-15-12-20-10-11-21(16-32)34(20)26(35)22-4-1-2-5-23(22)29/h1-9,13-14,20-21H,10-12,15-17H2 CMZQGKVDTVUQLY-UHFFFAOYSA-N 532239 US11208422, Example 80::US11208422, Example 81 Potassium channel subfamily K member 9 Homo sapiens 9.20 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532239&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362158 463795645 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126812 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H26ClFN6O2/c1-37-23-10-9-21(29)25(31-23)26(36)35-19-7-8-20(35)15-33(14-11-19)16-22-24(17-3-5-18(28)6-4-17)32-27-30-12-2-13-34(22)27/h2-6,9-10,12-13,19-20H,7-8,11,14-16H2,1H3 VMPXYJOLXYHOKB-UHFFFAOYSA-N 532241 US11208422, Example 82::US11208422, Example 83 Potassium channel subfamily K member 3 Human 30.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532241 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532241&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362547 463795646 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126813 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H26ClFN6O2/c1-37-23-10-9-21(29)25(31-23)26(36)35-19-7-8-20(35)15-33(14-11-19)16-22-24(17-3-5-18(28)6-4-17)32-27-30-12-2-13-34(22)27/h2-6,9-10,12-13,19-20H,7-8,11,14-16H2,1H3 VMPXYJOLXYHOKB-UHFFFAOYSA-N 532241 US11208422, Example 82::US11208422, Example 83 Potassium channel subfamily K member 9 Homo sapiens 1.40 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532241 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532241&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362547 463795646 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126814 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H26ClFN6O2/c1-37-23-10-9-21(29)25(31-23)26(36)35-19-7-8-20(35)15-33(14-11-19)16-22-24(17-3-5-18(28)6-4-17)32-27-30-12-2-13-34(22)27/h2-6,9-10,12-13,19-20H,7-8,11,14-16H2,1H3 VMPXYJOLXYHOKB-UHFFFAOYSA-N 532241 US11208422, Example 82::US11208422, Example 83 Potassium channel subfamily K member 3 Human 410 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532241 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532241&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362547 463795646 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126815 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H26ClFN6O2/c1-37-23-10-9-21(29)25(31-23)26(36)35-19-7-8-20(35)15-33(14-11-19)16-22-24(17-3-5-18(28)6-4-17)32-27-30-12-2-13-34(22)27/h2-6,9-10,12-13,19-20H,7-8,11,14-16H2,1H3 VMPXYJOLXYHOKB-UHFFFAOYSA-N 532241 US11208422, Example 82::US11208422, Example 83 Potassium channel subfamily K member 9 Homo sapiens 17.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532241 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532241&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362547 463795646 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126816 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cn1)CC2 InChI=1S/C27H27ClN6O2/c1-36-25-7-4-5-22(30-25)27(35)34-19-9-10-20(34)16-32(14-12-19)17-23-26(21-11-8-18(28)15-29-21)31-24-6-2-3-13-33(23)24/h2-8,11,13,15,19-20H,9-10,12,14,16-17H2,1H3 NTSAEQWDMDAIAN-UHFFFAOYSA-N 532243 US11208422, Example 84::US11208422, Example 85 Potassium channel subfamily K member 3 Human 350 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532243 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532243&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137361847 463795647 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126817 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cn1)CC2 InChI=1S/C27H27ClN6O2/c1-36-25-7-4-5-22(30-25)27(35)34-19-9-10-20(34)16-32(14-12-19)17-23-26(21-11-8-18(28)15-29-21)31-24-6-2-3-13-33(23)24/h2-8,11,13,15,19-20H,9-10,12,14,16-17H2,1H3 NTSAEQWDMDAIAN-UHFFFAOYSA-N 532243 US11208422, Example 84::US11208422, Example 85 Potassium channel subfamily K member 9 Homo sapiens 25.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532243 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532243&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137361847 463795647 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126818 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cn1)CC2 InChI=1S/C27H27ClN6O2/c1-36-25-7-4-5-22(30-25)27(35)34-19-9-10-20(34)16-32(14-12-19)17-23-26(21-11-8-18(28)15-29-21)31-24-6-2-3-13-33(23)24/h2-8,11,13,15,19-20H,9-10,12,14,16-17H2,1H3 NTSAEQWDMDAIAN-UHFFFAOYSA-N 532243 US11208422, Example 84::US11208422, Example 85 Potassium channel subfamily K member 3 Human 6300 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532243 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532243&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137361847 463795647 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126819 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cn1)CC2 InChI=1S/C27H27ClN6O2/c1-36-25-7-4-5-22(30-25)27(35)34-19-9-10-20(34)16-32(14-12-19)17-23-26(21-11-8-18(28)15-29-21)31-24-6-2-3-13-33(23)24/h2-8,11,13,15,19-20H,9-10,12,14,16-17H2,1H3 NTSAEQWDMDAIAN-UHFFFAOYSA-N 532243 US11208422, Example 84::US11208422, Example 85 Potassium channel subfamily K member 9 Homo sapiens 370 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532243 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532243&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137361847 463795647 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126820 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H27ClN6O2/c1-36-24-5-2-4-22(30-24)26(35)34-20-10-11-21(34)16-32(15-12-20)17-23-25(18-6-8-19(28)9-7-18)31-27-29-13-3-14-33(23)27/h2-9,13-14,20-21H,10-12,15-17H2,1H3 HAQMMDHFULLOTD-UHFFFAOYSA-N 532245 US11208422, Example 86::US11208422, Example 87 Potassium channel subfamily K member 3 Human 340 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532245 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532245&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 142494578 463795648 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126821 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H27ClN6O2/c1-36-24-5-2-4-22(30-24)26(35)34-20-10-11-21(34)16-32(15-12-20)17-23-25(18-6-8-19(28)9-7-18)31-27-29-13-3-14-33(23)27/h2-9,13-14,20-21H,10-12,15-17H2,1H3 HAQMMDHFULLOTD-UHFFFAOYSA-N 532245 US11208422, Example 86::US11208422, Example 87 Potassium channel subfamily K member 9 Homo sapiens 28.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532245 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532245&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 142494578 463795648 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126822 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H27ClN6O2/c1-36-24-5-2-4-22(30-24)26(35)34-20-10-11-21(34)16-32(15-12-20)17-23-25(18-6-8-19(28)9-7-18)31-27-29-13-3-14-33(23)27/h2-9,13-14,20-21H,10-12,15-17H2,1H3 HAQMMDHFULLOTD-UHFFFAOYSA-N 532245 US11208422, Example 86::US11208422, Example 87 Potassium channel subfamily K member 3 Human 1600 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532245 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532245&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 142494578 463795648 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126823 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H27ClN6O2/c1-36-24-5-2-4-22(30-24)26(35)34-20-10-11-21(34)16-32(15-12-20)17-23-25(18-6-8-19(28)9-7-18)31-27-29-13-3-14-33(23)27/h2-9,13-14,20-21H,10-12,15-17H2,1H3 HAQMMDHFULLOTD-UHFFFAOYSA-N 532245 US11208422, Example 86::US11208422, Example 87 Potassium channel subfamily K member 9 Homo sapiens 210 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532245 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532245&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 142494578 463795648 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126824 Fc1ccccc1C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H26ClFN4O/c29-20-10-8-19(9-11-20)27-25(33-15-4-3-7-26(33)31-27)18-32-16-14-21-12-13-22(17-32)34(21)28(35)23-5-1-2-6-24(23)30/h1-11,15,21-22H,12-14,16-18H2 WKFGLINXRSPXAG-UHFFFAOYSA-N 532228 US11208422, Example 69::US11208422, Example 88::US11208422, Example 89 Potassium channel subfamily K member 3 Human 91.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532228&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362230 463795635 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126825 Fc1ccccc1C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H26ClFN4O/c29-20-10-8-19(9-11-20)27-25(33-15-4-3-7-26(33)31-27)18-32-16-14-21-12-13-22(17-32)34(21)28(35)23-5-1-2-6-24(23)30/h1-11,15,21-22H,12-14,16-18H2 WKFGLINXRSPXAG-UHFFFAOYSA-N 532228 US11208422, Example 69::US11208422, Example 88::US11208422, Example 89 Potassium channel subfamily K member 9 Homo sapiens 1.60 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532228&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362230 463795635 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126826 Fc1ccccc1C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H26ClFN4O/c29-20-10-8-19(9-11-20)27-25(33-15-4-3-7-26(33)31-27)18-32-16-14-21-12-13-22(17-32)34(21)28(35)23-5-1-2-6-24(23)30/h1-11,15,21-22H,12-14,16-18H2 WKFGLINXRSPXAG-UHFFFAOYSA-N 532228 US11208422, Example 69::US11208422, Example 88::US11208422, Example 89 Potassium channel subfamily K member 3 Human 310 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532228&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362230 463795635 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126827 Fc1ccccc1C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H26ClFN4O/c29-20-10-8-19(9-11-20)27-25(33-15-4-3-7-26(33)31-27)18-32-16-14-21-12-13-22(17-32)34(21)28(35)23-5-1-2-6-24(23)30/h1-11,15,21-22H,12-14,16-18H2 WKFGLINXRSPXAG-UHFFFAOYSA-N 532228 US11208422, Example 69::US11208422, Example 88::US11208422, Example 89 Potassium channel subfamily K member 9 Homo sapiens 19.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532228&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362230 463795635 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126828 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H28ClN5O2/c1-36-26-7-4-5-23(30-26)28(35)34-21-12-13-22(34)17-32(16-14-21)18-24-27(19-8-10-20(29)11-9-19)31-25-6-2-3-15-33(24)25/h2-11,15,21-22H,12-14,16-18H2,1H3 BAEIXOAVLHXXML-UHFFFAOYSA-N 532229 US11208422, Example 70::US11208422, Example 90::US11208422, Example 91 Potassium channel subfamily K member 3 Human 43.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532229 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532229&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362165 463795636 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126829 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H28ClN5O2/c1-36-26-7-4-5-23(30-26)28(35)34-21-12-13-22(34)17-32(16-14-21)18-24-27(19-8-10-20(29)11-9-19)31-25-6-2-3-15-33(24)25/h2-11,15,21-22H,12-14,16-18H2,1H3 BAEIXOAVLHXXML-UHFFFAOYSA-N 532229 US11208422, Example 70::US11208422, Example 90::US11208422, Example 91 Potassium channel subfamily K member 9 Homo sapiens 2.80 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532229 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532229&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362165 463795636 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126830 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H28ClN5O2/c1-36-26-7-4-5-23(30-26)28(35)34-21-12-13-22(34)17-32(16-14-21)18-24-27(19-8-10-20(29)11-9-19)31-25-6-2-3-15-33(24)25/h2-11,15,21-22H,12-14,16-18H2,1H3 BAEIXOAVLHXXML-UHFFFAOYSA-N 532229 US11208422, Example 70::US11208422, Example 90::US11208422, Example 91 Potassium channel subfamily K member 3 Human 290 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532229 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532229&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 137362165 463795636 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126831 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H28ClN5O2/c1-36-26-7-4-5-23(30-26)28(35)34-21-12-13-22(34)17-32(16-14-21)18-24-27(19-8-10-20(29)11-9-19)31-25-6-2-3-15-33(24)25/h2-11,15,21-22H,12-14,16-18H2,1H3 BAEIXOAVLHXXML-UHFFFAOYSA-N 532229 US11208422, Example 70::US11208422, Example 90::US11208422, Example 91 Potassium channel subfamily K member 9 Homo sapiens 5.50 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532229 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532229&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 137362165 463795636 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126832 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H27ClFN5O3/c1-37-25-10-9-22(30)27(32-25)28(36)35-20-11-13-33(14-21(35)17-38-16-20)15-23-26(18-5-7-19(29)8-6-18)31-24-4-2-3-12-34(23)24/h2-10,12,20-21H,11,13-17H2,1H3 LCTJPPMPLZJFSE-UHFFFAOYSA-N 532051 3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-3-yl]methyl}-8-oxa-3,10-diazabicyclo[4.3.1]dec-10-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1)::US11208422, Example 11::US11208422, Example 12::US11208422, Example 92 Potassium channel subfamily K member 3 Human 85.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532051&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602402 463795483 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126833 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C28H27ClFN5O3/c1-37-25-10-9-22(30)27(32-25)28(36)35-20-11-13-33(14-21(35)17-38-16-20)15-23-26(18-5-7-19(29)8-6-18)31-24-4-2-3-12-34(23)24/h2-10,12,20-21H,11,13-17H2,1H3 LCTJPPMPLZJFSE-UHFFFAOYSA-N 532051 3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyridin-3-yl]methyl}-8-oxa-3,10-diazabicyclo[4.3.1]dec-10-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1)::US11208422, Example 11::US11208422, Example 12::US11208422, Example 92 Potassium channel subfamily K member 9 Homo sapiens 2.50 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532051&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602402 463795483 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126834 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H26ClFN6O3/c1-37-23-8-7-21(29)25(31-23)26(36)35-19-9-12-33(13-20(35)16-38-15-19)14-22-24(17-3-5-18(28)6-4-17)32-27-30-10-2-11-34(22)27/h2-8,10-11,19-20H,9,12-16H2,1H3 TUPUGKCVCFZDOC-UHFFFAOYSA-N 532162 3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-8-oxa-3,10-diazabicyclo[4.3.1]dec-10-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1)::US11208422, Example 13::US11208422, Example 14::US11208422, Example 93 Potassium channel subfamily K member 3 Human 340 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532162&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602416 463795593 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126835 COc1ccc(F)c(n1)C(=O)N1C2COCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H26ClFN6O3/c1-37-23-8-7-21(29)25(31-23)26(36)35-19-9-12-33(13-20(35)16-38-15-19)14-22-24(17-3-5-18(28)6-4-17)32-27-30-10-2-11-34(22)27/h2-8,10-11,19-20H,9,12-16H2,1H3 TUPUGKCVCFZDOC-UHFFFAOYSA-N 532162 3-{[2-(4-Chlorophenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-8-oxa-3,10-diazabicyclo[4.3.1]dec-10-yl](3-fluoro-6-methoxypyridin-2-yl)methanone (Enantiomer 1)::US11208422, Example 13::US11208422, Example 14::US11208422, Example 93 Potassium channel subfamily K member 9 Homo sapiens 12.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532162&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602416 463795593 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126836 COc1ccc(F)c(n1)C(=O)N1CC2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C28H27ClFN5O2/c1-37-25-12-11-22(30)27(32-25)28(36)35-15-18-5-10-21(35)16-33(14-18)17-23-26(19-6-8-20(29)9-7-19)31-24-4-2-3-13-34(23)24/h2-4,6-9,11-13,18,21H,5,10,14-17H2,1H3 PUABNNGKGQHSTR-UHFFFAOYSA-N 532252 US11208422, Example 94 Potassium channel subfamily K member 3 Human 3200 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532252&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602784 463795649 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126837 COc1ccc(F)c(n1)C(=O)N1CC2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C28H27ClFN5O2/c1-37-25-12-11-22(30)27(32-25)28(36)35-15-18-5-10-21(35)16-33(14-18)17-23-26(19-6-8-20(29)9-7-19)31-24-4-2-3-13-34(23)24/h2-4,6-9,11-13,18,21H,5,10,14-17H2,1H3 PUABNNGKGQHSTR-UHFFFAOYSA-N 532252 US11208422, Example 94 Potassium channel subfamily K member 9 Homo sapiens 110 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532252&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602784 463795649 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126838 COc1cccc(n1)C(=O)N1CC2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C28H28ClN5O2/c1-36-26-7-4-5-23(30-26)28(35)34-16-19-8-13-22(34)17-32(15-19)18-24-27(20-9-11-21(29)12-10-20)31-25-6-2-3-14-33(24)25/h2-7,9-12,14,19,22H,8,13,15-18H2,1H3 KPJAEPIZZOJZNP-UHFFFAOYSA-N 532253 US11208422, Example 95 Potassium channel subfamily K member 3 Human 4900 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532253 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532253&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602426 463795650 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126839 COc1cccc(n1)C(=O)N1CC2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cc1)C2 InChI=1S/C28H28ClN5O2/c1-36-26-7-4-5-23(30-26)28(35)34-16-19-8-13-22(34)17-32(15-19)18-24-27(20-9-11-21(29)12-10-20)31-25-6-2-3-14-33(24)25/h2-7,9-12,14,19,22H,8,13,15-18H2,1H3 KPJAEPIZZOJZNP-UHFFFAOYSA-N 532253 US11208422, Example 95 Potassium channel subfamily K member 9 Homo sapiens 710 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532253 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532253&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602426 463795650 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126840 COc1ccc(Cl)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H26Cl2N6O2/c1-37-23-10-9-21(29)25(31-23)26(36)35-19-7-8-20(35)15-33(14-11-19)16-22-24(17-3-5-18(28)6-4-17)32-27-30-12-2-13-34(22)27/h2-6,9-10,12-13,19-20H,7-8,11,14-16H2,1H3 UHONHSIREAHILI-UHFFFAOYSA-N 532254 US11208422, Example 99 Potassium channel subfamily K member 3 Human 290 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532254&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 155717796 463795651 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126841 COc1ccc(Cl)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(Cl)cc1)CC2 InChI=1S/C27H26Cl2N6O2/c1-37-23-10-9-21(29)25(31-23)26(36)35-19-7-8-20(35)15-33(14-11-19)16-22-24(17-3-5-18(28)6-4-17)32-27-30-12-2-13-34(22)27/h2-6,9-10,12-13,19-20H,7-8,11,14-16H2,1H3 UHONHSIREAHILI-UHFFFAOYSA-N 532254 US11208422, Example 99 Potassium channel subfamily K member 9 Homo sapiens 34.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532254&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 155717796 463795651 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126842 COc1ccc(Cl)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cn1)CC2 InChI=1S/C27H26Cl2N6O2/c1-37-24-10-8-20(29)25(32-24)27(36)35-18-6-7-19(35)15-33(13-11-18)16-22-26(21-9-5-17(28)14-30-21)31-23-4-2-3-12-34(22)23/h2-5,8-10,12,14,18-19H,6-7,11,13,15-16H2,1H3 WTQDUPFGUSAKFM-UHFFFAOYSA-N 532255 US11208422, Example 100 Potassium channel subfamily K member 3 Human 370 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532255&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 146602608 463795652 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126843 COc1ccc(Cl)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ccccn13)-c1ccc(Cl)cn1)CC2 InChI=1S/C27H26Cl2N6O2/c1-37-24-10-8-20(29)25(32-24)27(36)35-18-6-7-19(35)15-33(13-11-18)16-22-26(21-9-5-17(28)14-30-21)31-23-4-2-3-12-34(22)23/h2-5,8-10,12,14,18-19H,6-7,11,13,15-16H2,1H3 WTQDUPFGUSAKFM-UHFFFAOYSA-N 532255 US11208422, Example 100 Potassium channel subfamily K member 9 Homo sapiens 42.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532255&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 146602608 463795652 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126844 COc1ccc(Cl)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)CC2 InChI=1S/C30H33ClN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(36-15-4-14-32-30(36)34-27)18-35-16-13-22-9-10-23(17-35)37(22)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 MZXGYUKQNIIFLC-UHFFFAOYSA-N 532256 (3-Chloro-6-methoxypyridin-2-yl) [3-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,9-diazabicyclo[4.2.1]nonan-9-yl]methanone (Enantiomer 1)::US11208422, Example 101::US11208422, Example 106 Potassium channel subfamily K member 3 Human 400 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532256&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 142494550 463795653 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126845 COc1ccc(Cl)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)CC2 InChI=1S/C30H33ClN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(36-15-4-14-32-30(36)34-27)18-35-16-13-22-9-10-23(17-35)37(22)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 MZXGYUKQNIIFLC-UHFFFAOYSA-N 532256 (3-Chloro-6-methoxypyridin-2-yl) [3-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,9-diazabicyclo[4.2.1]nonan-9-yl]methanone (Enantiomer 1)::US11208422, Example 101::US11208422, Example 106 Potassium channel subfamily K member 9 Homo sapiens 16.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532256&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 142494550 463795653 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126846 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)CC2 InChI=1S/C30H33FN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(36-15-4-14-32-30(36)34-27)18-35-16-13-22-9-10-23(17-35)37(22)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 JUQCZQWJYSDLSU-UHFFFAOYSA-N 532257 US11208422, Example 102::US11208422, Example 103 Potassium channel subfamily K member 3 Human 170 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532257&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 142494576 463795654 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126847 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)CC2 InChI=1S/C30H33FN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(36-15-4-14-32-30(36)34-27)18-35-16-13-22-9-10-23(17-35)37(22)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 JUQCZQWJYSDLSU-UHFFFAOYSA-N 532257 US11208422, Example 102::US11208422, Example 103 Potassium channel subfamily K member 9 Homo sapiens 36.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532257&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 142494576 463795654 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126848 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)CC2 InChI=1S/C30H33FN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(36-15-4-14-32-30(36)34-27)18-35-16-13-22-9-10-23(17-35)37(22)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 JUQCZQWJYSDLSU-UHFFFAOYSA-N 532257 US11208422, Example 102::US11208422, Example 103 Potassium channel subfamily K member 3 Human 1400 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532257&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 142494576 463795654 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126849 COc1ccc(F)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)CC2 InChI=1S/C30H33FN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(36-15-4-14-32-30(36)34-27)18-35-16-13-22-9-10-23(17-35)37(22)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 JUQCZQWJYSDLSU-UHFFFAOYSA-N 532257 US11208422, Example 102::US11208422, Example 103 Potassium channel subfamily K member 9 Homo sapiens 200 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532257&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 142494576 463795654 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126850 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)CC2 InChI=1S/C30H34N6O2/c1-20(2)21-8-10-22(11-9-21)28-26(35-16-5-15-31-30(35)33-28)19-34-17-14-23-12-13-24(18-34)36(23)29(37)25-6-4-7-27(32-25)38-3/h4-11,15-16,20,23-24H,12-14,17-19H2,1-3H3 FFWMIRXDQSGXIF-UHFFFAOYSA-N 532259 US11208422, Example 104::US11208422, Example 105 Potassium channel subfamily K member 3 Human 600 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532259&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 142494574 463795655 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126851 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)CC2 InChI=1S/C30H34N6O2/c1-20(2)21-8-10-22(11-9-21)28-26(35-16-5-15-31-30(35)33-28)19-34-17-14-23-12-13-24(18-34)36(23)29(37)25-6-4-7-27(32-25)38-3/h4-11,15-16,20,23-24H,12-14,17-19H2,1-3H3 FFWMIRXDQSGXIF-UHFFFAOYSA-N 532259 US11208422, Example 104::US11208422, Example 105 Potassium channel subfamily K member 9 Homo sapiens 31.0 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532259&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 142494574 463795655 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126852 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)CC2 InChI=1S/C30H34N6O2/c1-20(2)21-8-10-22(11-9-21)28-26(35-16-5-15-31-30(35)33-28)19-34-17-14-23-12-13-24(18-34)36(23)29(37)25-6-4-7-27(32-25)38-3/h4-11,15-16,20,23-24H,12-14,17-19H2,1-3H3 FFWMIRXDQSGXIF-UHFFFAOYSA-N 532259 US11208422, Example 104::US11208422, Example 105 Potassium channel subfamily K member 3 Human 3700 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532259&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 142494574 463795655 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126853 COc1cccc(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)CC2 InChI=1S/C30H34N6O2/c1-20(2)21-8-10-22(11-9-21)28-26(35-16-5-15-31-30(35)33-28)19-34-17-14-23-12-13-24(18-34)36(23)29(37)25-6-4-7-27(32-25)38-3/h4-11,15-16,20,23-24H,12-14,17-19H2,1-3H3 FFWMIRXDQSGXIF-UHFFFAOYSA-N 532259 US11208422, Example 104::US11208422, Example 105 Potassium channel subfamily K member 9 Homo sapiens 370 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532259&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 142494574 463795655 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2 1126854 COc1ccc(Cl)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)CC2 InChI=1S/C30H33ClN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(36-15-4-14-32-30(36)34-27)18-35-16-13-22-9-10-23(17-35)37(22)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 MZXGYUKQNIIFLC-UHFFFAOYSA-N 532256 (3-Chloro-6-methoxypyridin-2-yl) [3-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,9-diazabicyclo[4.2.1]nonan-9-yl]methanone (Enantiomer 1)::US11208422, Example 101::US11208422, Example 106 Potassium channel subfamily K member 3 Human 1300 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=7196&target=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532256&enzyme=Potassium+channel+subfamily+K+member+3&column=ki&startPg=0&Increment=50&submit=Search 142494550 463795653 1 MKRQNVRTLALIVCTFTYLLVGAAVFDALESEPELIERQRLELRQQELRARYNLSQGGYEELERVVLRLKPHKAGVQWRFAGSFYFAITVITTIGYGHAAPSTDGGKVFCMFYALLGIPLTLVMFQSLGERINTLVRYLLHRAKKGLGMRRADVSMANMVLIGFFSCISTLCIGAAAFSHYEHWTFFQAYYYCFITLTTIGFGDYVALQKDQALQTQPQYVAFSFVYILTGLTVIGAFLNLVVLRFMTMNAEDEKRDAEHRALLTRNGQAGGGGGGGSAHTTDTASSTAAAGGGGFRNVYAEVLHFQSMCSCLWYKSREKLQYSIPMIIPRDLSTSDTCVEQSHSSPGGGGRYSDTPSRRCLCSGAPRSAISSVSTGLHSLSTFRGLMKRRSSV Potassium channel subfamily K member 3 KCNK3_HUMAN O14649 Q53SU2 1126855 COc1ccc(Cl)c(n1)C(=O)N1C2CCC1CN(Cc1c(nc3ncccn13)-c1ccc(cc1)C(C)C)CC2 InChI=1S/C30H33ClN6O2/c1-19(2)20-5-7-21(8-6-20)27-25(36-15-4-14-32-30(36)34-27)18-35-16-13-22-9-10-23(17-35)37(22)29(38)28-24(31)11-12-26(33-28)39-3/h4-8,11-12,14-15,19,22-23H,9-10,13,16-18H2,1-3H3 MZXGYUKQNIIFLC-UHFFFAOYSA-N 532256 (3-Chloro-6-methoxypyridin-2-yl) [3-{[2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl]methyl}-3,9-diazabicyclo[4.2.1]nonan-9-yl]methanone (Enantiomer 1)::US11208422, Example 101::US11208422, Example 106 Potassium channel subfamily K member 9 Homo sapiens 140 US Patent 10.7270/Q2CR5XHD aid1806237 US11208422 Delbeck, M; Hahn, M; Muller, T; Lustig, K; Anlahr, J; Collins, K; Nicolai, J; Beck-Broichsitter, M; Albus, U; Gehring, D; Rosenstein, B; Dang, H; Duan, D; Yang, J; Chen, D 12/28/2021 5/3/2022 Bayer Pharma Aktiengesellschaft; Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=532256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006329&target=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=532256&enzyme=Potassium+channel+subfamily+K+member+9&column=ki&startPg=0&Increment=50&submit=Search 142494550 463795653 1 MKRQNVRTLSLIVCTFTYLLVGAAVFDALESDHEMREEEKLKAEEIRIKGKYNISSEDYRQLELVILQSEPHRAGVQWKFAGSFYFAITVITTIGYGHAAPGTDAGKAFCMFYAVLGIPLTLVMFQSLGERMNTFVRYLLKRIKKCCGMRNTDVSMENMVTVGFFSCMGTLCIGAAAFSQCEEWSFFHAYYYCFITLTTIGFGDYVALQTKGALQKKPLYVAFSFMYILVGLTVIGAFLNLVVLRFLTMNSEDERRDAEERASLAGNRNSMVIHIPEEPRPSRPRYKADVPDLQSVCSCTCYRSQDYGGRSVAPQNSFSAKLAPHYFHSISYKIEEISPSTLKNSLFPSPISSISPGLHSFTDHQRLMKRRKSV Potassium channel subfamily K member 9 KCNK9_HUMAN Q9NPC2 Q2M290 Q540F2